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Abstract 
Mast cells (MCs) are the key effector cells in immunoglobulin E (IgE) -mediated 
allergic disease such as atopic asthma, allergic rhinitis and atopic dermatitis, 
but also participate in a variety of IgE-independent biologic responses. MCs can 
produce and secrete mediators influencing various aspects of the biology of 
dendritic cells, T cells, and B cells thus acting like regulatory cells (Merluzzi et 
al., 2010). With the advent of the MC deficient mice and selective engraftment 
with in-vitro-generated bone marrow derived mast cells (BMMC), it was shown 
that these cells are critical for the initiation of acute inflammatory responses. In 
several models for acute inflammation, the recruitment of neutrophils turned out 
to be initiated by MCs, which are localized at site of infection (Doener et al., 
2013). In this study we showed that neutrophils and MCs interact through cell-
cell contacts and via soluble factors. This cross-talk is bidirectional resulting in 
neutrophils activation and down-regulation of some of MC functions. Since the 
two cells are known to be involved in regulation of B cells activation, 
proliferation and immunoglobulin secretion we further investigated the role of 
their crosstalk in regulation of B cell response.  We demonstrated an increased 
B cells survival in presence of conditioned media of neutrophils-MC co-cultures 
probably due to an increased presence of soluble BAFF. To extend the study to 
effect of this cross-talk on adaptive immune response we performed an in vivo 
T-independent immunization in Wild Type mice, in mast cell-deficient KitW-
sh/KitW-sh mice and KitW-sh/KitW-sh mice engrafted with bone marrow derived MC. 
In parallel T-independent immunization was performed in WT, KitW-sh/KitW-sh 
mice and in reconstituted KitW-sh/KitW-sh mice depleted for neutrophils and 
immunoglobulin production among mice groups was compared. We discovered 
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that the MCs and neutrophils together seem to regulate Ig production after T-
independent immunization in a reciprocal way.  
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1. INTRODUCTION 
1.1. Innate and adaptive immune system crosstalk  	  	  
The innate immune system constitutes the first line of host defense during 
infection and therefore plays a crucial role in the early recognition and 
subsequent triggering of pro-inflammatory response to invading pathogens 
(Medzhitov & Janeway, 2000). The adaptive immune system, on the other 
hand, is responsible for elimination of pathogens in the late phase of infection 
and generation of immunological memory. Whereas the adaptive immune 
response is characterized by specificity developed by clonal gene 
rearrangements from a broad repertoire of antigen-specific receptors on 
lymphocytes, the innate response is mediated primarily by phagocytic cells, 
antigen-presenting cells (APCs), such as granulocytes, macrophages, dendritic 
cells (DCs) and MCs and has been regarded as relatively nonspecific. However, 
the innate immune system is no longer regarded as a primitive, nonspecific 
system involved only in destroying and presenting antigen to cells of the 
adaptive immune system. In fact, it now appears that innate and adaptive 
immune responses are much more intimately connected than initially believed, 
and several important findings support the idea that the innate immune system, 
besides being essential for early pathogen recognition, is also involved in the 
activation and shaping adaptive immunity (Iwasaki & Medzhitov, 2004). Thus, 
the non clonogenic germ-line-encoded pattern recognition receptors (PPR), as 
the toll-like receptors (TLR), sense microbial compounds and bridge innate and 
adaptive immunity by activation of APCs (Werling, Jungi, & Bern, 2003). TLR-
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induced signaling via intracellular adaptor molecules, including MyD88 and 
TRIF, drives transcriptional activation of genes including pro-inflammatory 
cytokines cell activation markers (Kawasaki & Kawai, 2014) (Pasare & 
Medzhitov, 2005), and co-stimulatory molecules, which subsequently control 
the activation of antigen-specific adaptive immune response (Hivroz, Chemin, 
Tourret, & Bohineust, 2012). 
A critical element, in the interaction between the two arms of immune response, 
is the role played by dendritic cells (DCs), which represent “professional APC”. 
DCs endocytose and process antigen to peptide presented on the cell surface 
in association with Major Histocompatibility Complex (MHC) molecules (Hivroz 
et al., 2012). 
This presentation results in interaction with and stimulation of helper T (Th) cells 
or cytotoxic T (Tc) cells, which recognize peptide in association with either MHC 
class II or MHC class I respectively (Bousso, 2008) (Hivroz et al., 2012). 
Stimulation of Th lymphocytes produces the growth and differentiation factors 
(cytokines) essential for the B lymphocytes that have responded to a more 
intact form of the antigen and that differentiate into antibody-producing cells. 
The precise interaction between the cells depends on cognate ligand-receptor 
recognition between the B and Th lymphocytes. DCs also play a direct role with 
the stimulation of the B cells. Additionally, DCs show a reciprocal influence in 
the process of activation with other adaptive immune cells, as Th17, regulatory 
T (Treg) cells, and regulatory B (B reg) cells (Qian et al., 2012), or innate 
immune cells, such as mast cells (MCs) (Gri et al., 2012), natural killer (NK) 
cells and NKT cells. 
In the secondary lymphoid organs, the professional APCs, the DCs stimulate T 
cell to respond to antigen loading endocytosed antigenic peptides on both MHC 
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class I and MHC class II molecules, combined with secondary signals delivered 
by co-stimulatory molecules such ad CD80/86 (Guermonprez et al., 2003). Co-
stimulation can simply promote more efficient engagement of T cell receptor 
(TCR) molecules to enhance the initial activation, or can provide additional 
biochemically distinct signals to regulate cells division, increase cell survival or 
induce T cell effector functions, such as cytokines secretion or cytotoxicity 
(Zingoni et al., 2005). 
NK cells promote adaptive immune response through their production of type 1 
and type 2 cytokines or chemokines. For example, following viral infections, the 
NK cells production of INFγ plays a key role in the initial antiviral response, 
activating macrophages to secrete IL-12, crucial for T cell differentiation into 
Th1 effectors and for the development of CD8+ cytotoxic cells (Zingoni et al., 
2005). MCs and basophils express a number of B cell modulating molecules. 
MCs were shown to affect B cell survival, proliferation and to trigger IgE 
synthesis and differentiation into IgA secreting plasma cells. Basophils support 
B cell proliferation and promote plasma cells survival and Ig production 
(Merluzzi et al., 2014). 
Neutrophils have long been recognized for their protein-destroying and 
bactericidal properties. Neutrophils can secrete products that stimulate 
monocytes and macrophages; these secretions increase phagocytosis and the 
formation of reactive oxygen compounds involved in intracellular killing. 
Moreover, activated neutrophils release large amounts of B cell stimulating 
factors, such as B cell activating factor (BAFF) and proliferation-inducing ligand 
(APRIL). Recent findings have found neutrophils around marginal zone (MZ) of 
the spleen, a B cell area specialized in T-independent Ig responses to 
circulating antigen. Neutrophils colonized peri-MZ areas after post-natal 
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mucosal colonization by microbes and enhanced their B-helper function upon 
receiving reprogramming signals from splenic sinusoidal endothelial cells, 
including interleukin 10 (IL10). Splenic neutrophils induced Ig class switching, 
somatic hypermutation and antibody production by activating MZ B cells 
through a mechanism involving the cytokines BAFF, APRIL and IL 21 (Cerutti, 
Puga, & Cols, 2012). 
Dialogue between the innate and adaptive immune system is not one sided. 
Adaptive response, in fact, can support the function of the innate immune 
system. Antibodies secreted by B cell, for example, bind macrophages and 
other phagocytes by interaction with Fc receptors on these cells. Phagocytes 
recognize, internalize and destroy pathogens using these borrowed antibodies. 
This selective internalization enhances the ability of these cells to internalize 
and present these antigens to T cells increasing acquired responses (Clark & 
Kupper, 2005). 
Appropriate innate and acquired immune system interactions lead to highly 
efficient recognition and clearance of pathogens, but maladaptive interaction 
between these two system can result in harmful immunologic responses 
including allergy, autoimmunity and allograft rejection (Clark & Kupper, 2005). 
 
 T– Independent B cell response  1.1.1.	  	  
Mouse B cells are the effectors of humoral immunity and they are subdivided 
into two distinct lineages, B-1 and B-2, which differ from functional 
characteristics and anatomical localization. B-1 B cells have been considered to 
be part of the innate immune system, whereas B-2 B cells function primarily in 
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adaptive immune responses (Montecino-Rodriguez & Dorshkind, 2006). B-1 is a 
self-renewing population which is enriched in peritoneal and pleural cavities and 
constitute the first B cell population that appears early in life (Vitale, Mion, & 
Pucillo, 2010). B1 B cells start response to infection by T-independent 
mechanisms thanks to their capacity to produce antibodies that are specific for 
self-antigens and for pathogen expressed-molecules like Gram-positive 
bacteria, Lipopolysaccharide (LPS) of Gram negative bacteria and various viral 
and parasite-expressed antigens (Baumgarth, 2011).  For this reason, B1 cells 
play an important role in innate immunity by secreting large amounts of natural 
antibodies of the Immunoglobulin M (IgM) class, which can be produced without 
exposure to any environmental antigens or immunization. They, also, express a 
reduced number of B-cell receptor (BCR) specificities, compared to B-2 
follicular B cells that confirm their status of innate-like immune cells. 
Two subset of B1 cells can be distinguished: B1a deriving from fetal liver B cells 
and identify as IgMHi IgDLo CD11b+CD5+CD220Lo/+ and the similar CD5- B1b 
originating from BM-derived stem cells. 
B1a cells represent a unique lineage distinguished by specific ontologic, 
phenotypic and functional characteristic. It has been shown that B1-a cells 
spontaneously and constitutively generate “natural” immunoglobulin, which 
constitutes the vast majority of resting serum IgM and about half of resting IgA 
(Holodick, Vizconde, & Rothstein, 2014). 
While B1a B cells constitute a source of natural antibody (Ab) during early 
phases of infection, in contrast, B1b cells appear to be the primary source of 
dynamic T cell independent (TI) antibody production and long-term protection 
after bacterial infection such as Borrelia hermsii and Streptococcus 
pneumoniae. 
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B2 B cells, also known as “conventional” B cells, are produced from 
hematopoietic stem cells (HSCs) in the bone marrow during postnatal life and 
they constitute the predominant population of B lymphocytes found in spleen 
and lymph nodes. Their differentiation culminates in the generation of surface 
immunoglobulin M (sIgM) -expressing cells which then migrate to spleen, where 
they undergo further maturation into follicular (FO) or MZ B cells (Montecino-
Rodriguez & Dorshkind, 2006). This diverse progeny of distinct subpopulation 
respond to antigens both by T dependent and T independent mechanisms 
(Vitale et al., 2010).  
FO B cells, which are the dominating B-cell population in secondary lymphoid 
organs play an important role in adaptive immune responses. In contrast, the 
pre-activated phenotype of splenic MZ B cells qualifies them to participate in T-
independent immune responses via rapid antibody secretion after antigenic 
stimulation (Düber et al., 2009). Similar to B-1 B cells, in fact, MZ B cells 
express polyspecific antibodies that recognize T-cell independent antigens and 
highly respond to BAFF and to APRIL released by innate immune cells after the 
encounter with pathogens. Both cells are characterized by a state of active 
readiness, which involves elevated TLR expression, and ‘innate’ Ig receptors 
with poorly diversified antigen-binding variable regions that permit them to 
recognize multiple highly conserved microbial products (Cerutti, Puga, & Cols, 
2011). 
B cells responses, in fact, are classified as T-dependent (TD) or T-independent 
(TI) based on their necessity for T cells help in antibody production 
(Nussenzweig, 2006). 
In contrast to the large body of knowledge about cellular and molecular events 
in TD responses, little is known about cellular and molecular requirements of a 
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TI immune response (Martin, Zhou, Kearney, & B, 2002). 
T cell-dependent immune responses generally involve conventional (B2) B 
cells. By contrast, the other subset of B cells, B1 cells, produce antibodies in a 
T-independent manner. 
In T-cell dependent response, B cell activation by protein antigens requires 
binding of the antigen to the B cell surface immunoglobulin (Ig) and the co-
stimulation by antigen-specific T cells through CD40-CD40 ligand (CD40L) 
interaction and the secretion of cytokines (Fagarasan, 2000). 
T independent antigens, on the other hand, are able to initiate a serological 
response in absence of T-cell help. There are two type of TI antigens: type I 
and type II. The first one are mitogenic stimuli like LPS, CpG that elicit 
polyclonal B cell activation via TLRs, the other one are polysaccharides, 
glycolipids and nucleic acid that engage the B cell receptor (BCR) and induce 
antigen-specific B cell responses. 
These antigens are not processed and presented along with MHC proteins so 
they cannot be recognized by helper T cells and so TI- type I antigens can 
directly stimulate B cells without requirement of any other cell (Nussenzweig, 
2006). Type II TI antigens possess a highly organized, repeating structures that 
are able to activate naïve B cells in absence of CD4+ T cell help, by cross 
linking multiple BCRs on their surface. Additional signal is required by activated 
B cell to stimulate antibody production, via TLR stimulation or complement 
activation and CD21 stimulation (Grant et al., 2012). 
Moreover, also microenviromental signals from BAFF and APRIL receptors 
would integrate with those from Ig receptors and TLRs to optimize B cell 
survival, Ig production, Ig diversification and plasma cells differentiation (Cerutti 
et al., 2011). 
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1.2. Neutrophils 	  	  
Neutrophils, also known as neutrophilic granulocytes or polymorphonuclear 
leukocytes (PMN), are the most abundant white blood cells in the human 
circulation.  
They are one of the principal effector cells of the immune system and are the 
first leukocytes recruited in sites of microbial infection and tissue invasion 
(Nathan, 2006). 
Neutrophils are inherently short-lived cells with a half-life of only 6-10 hours in 
the circulation and rapidly undergo spontaneous apoptosis. In infected tissues 
their apoptosis can be delayed both by microbial constituents and pro-
inflammatory stimuli (Esmann et al., 2010).  
The role played by neutrophils in immunity has long been viewed as restricted 
to the acute phase of inflammation and to resistance against extracellular 
pathogens. Several studies have recently challenged this dogma and placed 
neutrophils as key effector cells in the regulation of adaptive immunity and in 
the resolution of inflammatory response (Jaillon et al., 2013). 
Recent findings, indeed, show that in addition to antimicrobial agents, 
neutrophils can also produce numerous cytokines, chemokines, and growth 
factors (Mantovani, Cassatella, Costantini, & Jaillon, 2011) and can direct the 
adaptive immune response by communicating with various cell types, including 
B cell, dendritic cells, T cells and mast cells (Scapini & Cassatella, 2014). 
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 Neutrophil biology 1.2.1.	  	  
Neutrophils that leave the bone marrow and enter the blood-stream are 
terminally differentiated cells with short lifespan. They originate from 
hematopoietic precursor under the instruction of growth factors (G-CSF) and 
cytokines (IL3). In the bone marrow, hematopoietic cells differentiate into 
myeloblasts, which have round nucleus, then into promyelocytes, which 
accumulate peroxidase-positive azurophil granules (primary granules). The next 
differentiation step is in myelocytes, with a prominent accumulation of 
peroxidase-negative granules (secondary granules), and less abundant 
azurophilic granules (Lieschke et al.,1994). In the final stages of this process, 
myelocytes differentiate in metemyelocytes, band cells, and finally, 
granulocytes with the presence of tertiary granules (Borregaard, 2010) Fig 
1.2.1. 
 
 
Fig 1.2.1 Neutrophil differentiation. Neutrophils differentiate in the bone marrow and mature neutrophils 
are released into peripheral blood. Mature neutrophils are unable to proliferate and undergo constitutive 
apoptosis (Eyles, Roberts, Metcalf, & Wicks, 2006). 
 
Granules formed continuously during differentiation process are classified into 
four groups: primary or azurophilic, secondary or specific, tertiary or gelatinase, 
and secretory vesicles. Azurophilic granules contain myeloperoxidase (MPO), 
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an enzyme critical to the oxidative burst (Nusse & Lindau, 1988) hydrolitic and 
bactericidal enzymes. Secondary granules contain lactoferrin and lysozyme, as 
well as chemoattractant receptors. Tertiary granules contain few antimicrobial 
agents but store numerous metalloproteases, such gelatinase and leukolysin. 
Granules are not only repository organelles for dangerous substances but also 
indispensable for nearly all neutrophilic activities during inflammation 
(Borregaard, Sørensen, & Theilgaard-Mönch, 2007). 
The union of antimicrobial proteins, receptors, and other membrane proteins in 
granules represent a potent mechanism to eliminate bacteria and provide a fast 
activation/degranulation mechanism during inflammation. 
 
 Neutrophil activation 1.2.2.	  	  
A wide variety of stimuli induce neutrophil degranulation, including C5a, formyl-
methionyl-leucyl-phenylalanine, LPS, platelet-activating factor, and tumor 
necrosis factor (TNF). Neutrophils also express Toll-like receptors TLR1 to 
TLR10, with the exception of TLR3, enabling them to initiate various potentially 
important immune responses upon recognition of pathogen-associated 
molecular patterns. (Borregaard et al., 2007)(Borregaard, 2010)(Prince, Whyte, 
Sabroe, & Parker, 2011). 
The mechanism underlying neutrophil recruitment to the tissues is divided in 
three key steps: rolling, firm adhesion (endothelium) and diapedesis Fig 1.2.2. 
The stimulants described above prompt endothelial cells to produce adhesion 
molecules on their luminal side: the P-selectins, E-selectins and several 
members of the integrin superfamily, the ICAMs (Borregaard, 2010). 
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On neutrophils surface, two constitutively expressed proteins are important for 
recognition of the endothelial inflammatory signals: the glycoprotein P-selectin 
glycoprotein ligand-1 (PSGL-1) and L-selectin (Hidari, Weyrich, Zimmerman, & 
sEver, 1997). After contact with endothelium, these molecules engage the P-E 
selectins of endothelial cells, resulting in selectin-mediated tethering of 
neutrophils to the vessel wall. This is followed by a characteristic rolling of 
neutrophils along the endothelium (Amulic, Cazalet, Hayes, Metzler, & 
Zychlinsky, 2012). After selectin-mediated rolling, neutrophils enter a “firm 
adhesion” state mediated by the β2 integrin family of proteins (LFA-1, Mac1). 
This state is characterized by the arrest of neutrophil rolls along the 
endothelium, interaction with selectins, chemoattractants, cytokines and 
bacterial products results in activation and clustering of β2 integrins on the 
surface of neutrophils (Constantin et al., 2000) (Liu et al., 2002). After crawling 
along the vessel and reaching the preferred site of transmigration they begin to 
migrate through the endothelial junctions in the site of inflammation. Here 
neutrophils release cytokines that recruit other immune cells, and it begins to 
implement its antimicrobial potential. Among the process employed there are 
engulfment of microbes via receptor-mediated phagocytosis, release of granular 
antimicrobial molecules through degranulation, and formation of neutrophils 
extracellular traps (NETs) (Amulic, Cazalet, Hayes, Metzler, & Zychlinsky, 
2012). 
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Figure 1.2.2 Migration of neutrophils to the sites of infection. This is a multi-step process in which 
chemoattractants are produced in response to an infection and neutrophils are recruited from blood by 
binding to adhesion molecules on luminal surface of endothelial cells. The process involves rolling, 
adhesion and migration of these cells through the endothelial cells (Robbins & Cotran 2009).  
 
1.2.2.1. Neutrophil Phagocytosis 	  	  
Neutrophils are efficient phagocytes and engulf microbes into phagosomes that 
rapidly fuse with the granules, exposing microorganisms to proteases, 
phospholipases and cationic peptides (Nordenfelt & Tapper, 2011). 
The first step in this process is the recognition of microbes. Neutrophils 
recognize pathogen-derived molecules including peptidoglycan, lipoproteins, 
lipoteichoic acid, LPS and flagellin.  
Like macrophages, neutrophils can internalize both opsonized and non-
opsonized particles. Two separate classes of receptors are especially important 
during this mechanism: Fcγ-receptors (CD32, CD1, CD64 and CD89) (Bredius 
et al., 1994) and the complement receptors (CR1 and CR3). 
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While complement-opsonized particles are internalized by gently “sinking” into 
the cell, Fcγ receptor ligation initiates the vigorous extension of pseudopods 
that surround and ultimately entrap the particle (Greenberg & Grinstein, 2002). 
Once formed, the vacuole undergoes a rapid series of remodeling events that 
alter its composition, conferring onto it the ability to kill pathogens and dispose 
of debris. Fusion of the phagosome with the neutrophil lysosomes leads to the 
formation of phagolysosome (Lee, Harrison, & Grinstein, 2003).  
 
1.2.2.2. Neutrophils ROS production 	  	  
Activation of primed neutrophils, by phagocytosis of opsonized bacteria or by 
frustrated phagocytosis, generates rapid production of ROS via the action of 
NADPH oxidase. This enzyme is a multi-component enzyme, assembled at the 
plasma membrane during priming, so resting neutrophils have very little 
capacity to produce ROS (Wright, Moots, Bucknall, & Edwards, 2010). 
Neutrophils, macrophages, endothelial produce two types of free radicals. The 
first type is represented by reactive oxygen intermediates that are formed in 
neutrophils by the activity of NADPH oxidase. The second type includes 
reactive nitrogen intermediates, the first member of them, nitric oxide being 
produced by nitric oxide synthase (Carter R. Kettlerworth, 2007).  
Reactive oxygen species most often cause damage of DNA, oxidations of 
amino acids in proteins, oxidations of polyunsaturated fatty acids in lipids (lipid 
peroxidation), and inactivation of specific enzymes by oxidation of co-factors. 
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1.2.2.3. Neutrophil NETS 	  	  
In addition to the well-known capacity of neutrophils to phagocytose and kill 
invading microorganisms neutrophils can capture and kill pathogens extra-
cellularly through the release of neutrophil extracellular traps (NETs) (Kirchner 
et al., 2012).  These traps are networks of extracellular fibres, primarily 
composed of DNA and various bactericidal proteins (neutrophil elastase, 
histones), which bind and disarm pathogens (Kaplan, 2013).  
There are three mechanisms of NETs release. Fig 1.2.2.3 
NETs can be released through a vesicular mechanism. Initially, neutrophils 
become rounded with uniformly condensed chromatin and then undergo 
nuclear envelope breakdown. Within these cells, small vesicles containing DNA 
can be seen in the cytoplasm near the plasma membrane. The DNA-containing 
vesicles eventually fuse with the plasma membrane, and NETs are released to 
trap bacteria. NETs can also be released through cell lysis, and this typically 
takes longer than the vesicular-mediated mechanism. The nuclear envelope is 
degraded, and chromatin decondensation occurs because of peptidyl arginine 
deiminase 4 (PAD4)-mediated citrullination of histones. NET release by 
mitochondria has also been observed, in one study, although the steps of this 
process remain poorly characterized (Phillipson & Kubes, 2011) . 
NET formation require NADPH oxidase (NOX) activity, disintegration of the 
nuclear envelope and most granule membranes, in concert with the citrullinating 
activity of PAD 4 on histones, they promote chromatin decondensation 
(Casanova, Abel, & Quintana-Murci, 2011) (Wang et al., 2009) (Li et al., 
2010)(Hemmers, Teijaro, Arandjelovic, & Mowen, 2011). 
During NET formation, neutrophils may die through a distinct cell death program 
Introduction	  
	   21	  
termed NETosis (Brinkmann et al., 2004). 
A variety of stimuli can trigger NETosis, including pathogens, pro-inflammatory 
cytokines interleukin 8 (IL-8), TNFα, activated platelets and endothelial cells, 
nitric oxide, monosodium urate crystals, anti-neutrophils cytoplasmic antibodies 
(ANCAs), and immune complexes (Yu & Su, 2013). 
 
 
Fig 1.2.2.3 Various mechanism of NETS NETs can be released through: a vescicular mechanism, trough 
cell lysis, by mitochondria (Phillipson & Kubes, 2011). 
 
 Neutrophil clearance 1.2.3.	  	  
Circulating numbers of neutrophils are determined by the rate of neutrophil 
production, storage, release, and clearance (Rankin, 2010). 
Maintenance of circulating, functional neutrophils and their robust recruitment to 
tissues in response to injury and/or microbial infection are critical for host 
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defense. Equally important are the processes for removal of these short-lived 
cells (Bratton & Henson, 2011). Because uncontrolled release of toxic 
substances from neutrophils can propagate the inflammatory response leading 
to tissue destruction, recognition of dying inflammatory neutrophils has a critical 
function for the resolution of inflammatory response (Esmann et al., 2010). 
Clearance of circulating neutrophils that do not enter the site of infection is 
mediated by macrophages in the liver, spleen and bone marrow. 
Neutrophils removal from either the circulating pool, or from tissues, depends 
on signals resulting from neutrophil death, activation or aging (Bratton & 
Henson, 2011). 
Macrophages present in the liver and spleen are part of the reticulo endothelial 
system and are in direct contact with blood. These macrophages recognize, 
bind and phagocytose circulating and at sites of inflammation apoptotic 
neutrophils (Rankin, 2010). 
A number of changes on the dying cell surface lead either to binding molecules 
which give rise to “eat me” signals or to direct engagement of macrophage 
receptors. These “eat me” signals include externalized phosatidylserine, altered 
lipids, changes in surface charges likely attributed to amino sugars, and 
exposure of intracellular molecules such as calreticulin, mitochondrial and 
nuclear constituents (Bratton & Henson, 2011). 
Clearance via bone marrow takes place in an age dependent manner.  
The chemokine CXCL12 is produced in the bone marrow and binds to CXCR4 
receptors on neutrophils. Circulating senescent neutrophils up-regulate 
expression of CXCR4 that binds chemokine CXCL12 highly produced in the 
bone marrow. Via the CXCR4/CXCL12 axis, these aging and pre-apoptotic 
neutrophils go back to the bone marrow where they are phagocytized by 
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macrophages (Rankin, 2010).  
The recognition of dying cells results in profound alterations in macrophages 
responses. TGFβ and/or IL10 production by macrophages exposed to 
neutrophils undergoing apoptosis suppresses pro-inflammatory cytokine, 
chemokine and eicosanoid production. Failure of neutrophil removal results in 
the so called  “nuclear dust” and it is present in many autoimmune disease 
(Bratton & Henson, 2011). 
 
 Neutrophils and B cells 1.2.4.	  	  
Recent studies have shown that neutrophils can release a broad array of 
preformed and newly synthesized mediators, including chemokines and 
cytokines. The long held view that neutrophils function exclusively in the innate 
phase of immune response has been challenged, in fact these molecules 
regulate mobilization and function of neutrophils, monocytes, DCs, NK cells, but 
also the recruitment and activation T cells and B cells (Cerutti, Puga, & Magri, 
2013). Neutrophils crosstalk with B cells derive by their binding to B cell-derived 
IgG and IgA on opsonized microbes and by their production of BAFF and 
APRIL, which are two TLR-inducible B cell-stimulating factors related to the 
ligand for the T cell molecule CD40 (CD40L) (Puga et al., 2012). Recent 
findings show, also, that neutrophils occupy peri-MZ areas of the spleen in the 
absence of infection. The splenic microenvironment stimulates conventional 
neutrophils to become B cell helper neutrophils (NHB) through a process that 
involves the delivery of neutrophils reprogramming signals from splenic 
sinusoidal endothelial cells and other cells (Cerutti et al., 2012). 
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NHB induce IgM secretion, as well as IgG and IgA, by stimulating MZ B cells via 
BAFF, APRIL, IL21 and CD40L (Cerutti et al., 2012). On their surface they 
present cell suppressive factors that suppress T cell proliferation in a contact 
dependent manner. By exerting this dual B cell helper and T cell suppressor 
function, NHB can maximize extra-follicular B-cell responses to TI antigens while 
minimizing follicular B cell responses to T dependent antigens and inflammation 
(Cerutti et al., 2012). 
 
1.3. Mast Cells 	  	  
Mast cells (MCs) play an important role in the initiation and regulation of 
immune response. They were first described by Paul Enrlich in 1878, on the 
basis of their staining characteristics and large granules content. He named 
them "Mastzellen" which means “well-fed cells” in belief that their granules 
contain deposits of nutrients (Ehrlich P. 1978). They have long been known to 
be central to the initiation of allergic disorders but they have also important role 
in host defense, in directing and/or mediating a protective immune response 
and also in inducing tolerance (Alvarez-Errico, Lessmann, & Rivera, 2009). 
 
 Mast cell biology 1.3.1.	  	  
MCs are derived from hematopoietic progenitor cells but not ordinarily circulate 
in mature form: after migration of their precursors to the vascularized tissues or 
serosal cavities in which they will reside they locally differentiate and mature 
(Marone, Galli, & Kitamura, 2002). 
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Maturation of the MC precursors is dependent on stem cell factor (SCF) 
expressed on the surface of fibroblasts, stromal cells, and endothelial cells 
(Arinobu et al., 2005) and interleukin 3 (IL3).	  	  
MCs are strategically located along the microvasculature in tissues in close 
contact with the external environment, such as the skin, lung and intestine.  
There are two main MC populations in mice, based on their secretory granules: 
the connective tissue MCs (CTMC) and mucosal MCs (MMC). Fig1.3.1 Safranin 
postive granules of CTMC contain heparin proteoglycans and mouse mast cells 
protease 4 (mMCP4), 5 and 6. Safranin negative granules of MMC express 
mMCP 1 or 2 (Godfraind et al., 1998). Human MCs are divided in two 
population in relation of neutral protease content. They contain good levels of 
tryptase, chymase a cathepsin G-like protease and carboxypeptidase: MCTC 
contain tryptase and chymase MCT contain only tryptase (Metcalfe, Baram, & 
Mekori, 1997). 
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Fig 1.3.1 MCs in mice or humans can be divided into populations dependent by anatomical location, 
secretory granules and neural proteases content (Galli, Borregaard, & Wynn, 2011) 
 
MCs are capable of reacting, both within minutes and over hours, to a variety of 
physical, biological and chemical stimuli with either local or systemic effects Fig 
1.3.1.2. 
 
 
Fig 1.3.1.2 MC timing reaction MCs can respond to different stimuli in different time point. In seconds by 
releasing preformed mediators, in minutes producing eicosanoid mediators. In a second wave of response, 
MCs begin to release de novo synthesized mediators (Abraham & St John, 2010). 
They participate in the innate and acquired immune response and play a key 
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role in many immunological and inflammatory reactions. A beneficial role for 
these cells has been describe in defense against bacteria, virus and parasites 
(Galli, Nakae, & Tsai, 2005). 
Degranulation of activated cells results in the secretion of preformed mediators 
that are stored in the cells’ cytoplasmic granules, growth factors, cytokines and 
chemokines. In contrast, proinflammatory lipid mediators are newly synthesized. 
These MC-derived mediators generate the early initiation phase (vascular 
reaction and exudation) and contribute to the late phase (leukocyte 
accumulation and wound healing) of allergic inflammation (Mekori & Metcalfe, 
2000). 
The best studied mechanism by which MCs accomplish immunologically 
specific function is through antigen and IgE-dependent aggregation of the high 
affinity IgE receptor FcεRI (Kalesnikoff & Galli, 2008). However, MCs can be 
activated to perform important effector and immunomodulatory functions by 
many mechanisms that are independent of IgE.  
 
 Mast cell receptors 1.3.2.	  	  
MCs present on their surface an array of immune-response receptors and other 
surface molecules that confer the advanced capability to react to many 
nonspecific and specific stimuli.  
The most important stimulatory receptors of MCs include the FcεRI, c-Kit 
(receptor for stem cell factor), IgG receptors like FcγRI (or CD64) and FcγRIII 
(or CD16), complement proteins and TLRs. Many of these receptors contain 
immuno-receptor tyrosine-based activation motifs (ITAMs) that are essential for 
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activating signal. 
The multivalent binding of Ag to receptor-bound IgE and subsequent 
aggregation of the FcεRI provide triggers for MC activation. Ag aggregation of 
IgE-occupied FcεRI results in phosphorylation of immunoreceptor tyrosine 
based activation motifs by Lyn kinase (Lyn), receptor association and activation 
of Syk kinase (Syk), and inclusion of the FcεRI in lipid rafts (Frossi, De Carli, & 
Pucillo, 2004). 
C-kit or CD117 is a receptor tyrosine kinase type III, which binds to stem cell 
factor (SCF). When this receptor binds SCF it forms a dimer that activates its 
intrinsic tyrosin kinase activity that activates signal transduction molecules that 
propagate signals in the cells. 
The signaling pathways activated by triggering the IgG receptor generally 
resemble those observed following FcεRI aggregation that induces 
phosphorylation of Src kinases and p72 and subsequent activation of multiple 
substrates (Okayama, Tkaczyk, Metcalfe, & Gilfillan, 2003). 
 
 Mast cell signaling via FcεRI 1.3.3.	  	  
MC activation may be initiated upon interaction of a multivalent antigen 
(allergen) with specific IgE antibody attached to the cell membrane via the high 
affinity receptor, FcεRI (Mekori & Metcalfe, 2000). 
FcεRI is a member of the Fc receptor family and it’s the high affinity receptor for 
the crystalizable fragment (Fc) of IgE. It is a tetrameric receptor complex 
consisting of one alpha, one beta and two disulfide bridge connected gamma 
chains. 
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 FcεRI binds monovalent IgE antibodies secreted by plasmacells. The most 
potent MC responses are seen when antigen-specific IgE bound to FcεRI 
encounters the specific antigen (Alvarez-Errico et al., 2009).  
Ag aggregation of IgE-occupied FcεRI results in phosphorylation of immune 
receptor tyrosine based activation motifs (ITAM) by Lyn kinase since FcεRI 
lacks intrinsic tyrosine kinase activity.	   Once activated, Fyn, Lyn and Syk 
contribute to the formation of multi-molecular signaling complexes that are 
coordinated by adaptors, like LAT1 and 2, Gab2,Grb2,Gads, among others  
(Alvarez-Errico et al., 2009). 
When modified by FcεRI-induced phosphorylation, LAT forms a molecular 
complex that includes the adapters SLP-76, Grb2, phospholipase Cγ1 (PLCγ1), 
and the guanine nucleotide exchange factor, Vav1. 
IP3 release Ca2+ form intracellular stores as it binds to receptors in 
endoplasmic reticulum (ER) and activates store-operated calcium channels for 
the influx of Ca2+ allowing the regulation of later events of the signaling 
cascade (Frossi, De Carli, & Pucillo, 2004). 
MC activation results in the release of a variety of allergic mediators that are 
stored in intracellular granules and initiate de novo synthesis and secretion of 
inflammatory lipid mediators and a wide range of cytokines and chemokines 
(Blank & Rivera, 2004). 
 
 Direct activation by pathogens 1.3.4.	  	  
TLR are a family of pattern-recognition receptors that play an important role in 
host defense. MCs express a range of TLRs, including TLR1, 2, 3, 4, 6 and 9. 
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TLRs are involved in the specific recognition of different pathogens: Gram 
positive and -negative bacteria are recognized by TLR2 and TLR4, respectively, 
and flagellin is recognized by TLR5, dsRNA is recognized by TLR3, and 
unmethylated CpG DNA is recognized by TLR9 (Frossi et al., 2004). TLR 
signaling pathways arise from intra-cytoplasmic Toll-Interleukin receptors (TIR) 
domains, which are conserved among all TLRs. TIR domain-containing 
adaptors, such as MyD88, TIRAP, and TRIF, modulate TLR signaling pathways. 
MyD88 is essential for the induction of inflammatory cytokines triggered by all 
TLRs. TIRAP is specifically involved in the MyD88-dependent pathway via 
TLR2 and TLR4, whereas TRIF is implicated in the TLR3- and TLR4- MyD88-
independent pathway (Takeda & Akira, 2004). 
An additional mechanism of direct interaction of mast cells with pathogens that 
leads to their activation is mediated by the protein CD48, which binds to the 
fimbrial protein FimH on gram negative bacteria (Rao & Brown, 2008). 
 
 Mast cell mediators 1.3.5.	  	  
Mature MCs possesses numerous granules that store a wide range of potent, 
biologically active mediators. Fig 1.3.5 
Mediators can be release in two mode: in the classical anaphylactic 
degranulation (AND) mode, in which the entire contents of each granule are 
released by exocytosis immediately after cells activation; in a piecemeal 
degranulation (PMD), in which granules contents are released in a slow, 
progressive manner (Rao & Brown, 2008). 
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The first mechanism of degranulation is responsible of immediate Type I 
hypersensitivity and innate immune responses, the second one is thought to 
play a role in chronic inflammatory disorders and cancers. 
MC mediators can be divided in three categories: a) preformed mediators such 
as proteoglycans, histamine, neutral proteases and certain cytokines, in 
particular TNFα which are stored within the cytoplasmic MC granules and 
instantaneously released after activation; b) de novo synthetized mediators 
such as cytokines, chemokines growth and angiogenic factors that start to be 
synthetized after MC activation and c) lipid mediators that are newly 
synthesized following activation like prostaglandins, leukotrienes or platelet –
activating factor (Galli et al 2005). 
These mediators are important for regulate both innate and acquired immunity 
in fact they are able to regulate immune-cell trafficking and activation. Among 
early released MC products, TNFα play a crucial role in inducing the early influx 
of neutrophils promoting the clearance of pathogens. Histamine is the most 
abundant vasoactive amine stored in MCs and it exerts many effect pertinent to 
the allergic response like vasodilation, increased vaso-permeability and it drive 
dendritic cells migration and activation.  
MCs can influence the polarity of T cell responses by releasing Th2 polarizing 
cytokines like IL-4, IL-10 and IL-13. Among MC pre-synthesized mediators, 
protease group is the largest one. Serin proteases, chymase and tryptase are 
the major protein components in granules. They offer protection against 
parasites and venoms, and favor the expulsion of nematodes (Metz & Maurer, 
2007). MCs are thought to be crucial for the maintenance of tissue integrity and 
function. They produce nerve growth factor (NGF), platelet derived growth 
factor (PDGF), vascular endothelial growth factor (VEGF), fibroblast growth 
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factor 2 (FGF 2) that induce proliferation of epithelial cells and fibroblasts, so 
they can influence wound healing in every step. MCs are important in the 
homeostasis of organs that undergo continuous growth and remodeling such as 
hair follicles and bones. IL-1, transforming growth factor (TGF-β), IL-6, and 
histamine, in fact, could influence osteoclast recruitment and development (Rao 
& Brown, 2008). 
MCs have also anti-inflammatory properties, MC-derived IL-10, TGF-β and 
histamine have been purposed as modulators of the severity of the illness. 
These data confirm the ability of MCs to suppress the development and 
magnitude of the adaptive immune response (Depinay, Hacini, Beghdadi, 
Peronet, & Mécheri, 2006). 
 
Fig 1.3.5 MC mediators: 
activated MCs release mediators: 
preformed granules; cytokines 
and chemokies, newly synthetized 
mediators.  (Pundir & Kulka, 2010) 
 
 
 
 
 
 Mast cells and B cells 1.3.6.	  	  
MCs have long been known for their participation in pathological allergic 
reactions characterized by dysregulated production of the inflammatory 
antibody isotype IgE, but also participate in a variety of IgE independent 
biologic responses (Cerutti et al., 2012). Several studies revealed the role of 
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mast cells in the development of adaptive immune responses, including 
antibody production B cells. MCs can influence B cell development and isotype 
class switching through the release of some cytokines, such as IL-4, IL-5, IL-6 
and IL-13 and surface molecules such as CD40L (Gri et al., 2012). The 
interaction between CD40 and CD40L, together with MCs derived cytokines, 
were involved in the differentiation of B cells into CD138+ plasma cells and in 
selective IgA secretion and IgE production (Merluzzi et al., 2010). Moreover, un-
stimulated MCs are able to induce resting B cells to proliferate and become 
IgM-producing cells.  
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2. AIM OF THE WORK  
MCs are strategically located along the microvasculature within tissues in close 
contact with the external environment, such as the skin, lung and intestine and 
can rapidly respond to a variety of stimuli even in absence of IgE antibodies (R. 
Schramm & Thorlacius, 2004). By releasing a multi-faceted spectrum of pro-
inflammatory mediators, such as cytokines and chemokines they could 
coordinate the trafficking and function of different circulating cells like 
neutrophils (Rene Schramm, Schaefer, Menger, & Thorlacius, 2002). 
Neutrophils are the most abundant white blood cells in humans. In addition to 
their crucial role in protecting against infections, recent evidence suggests that 
neutrophils are also key components of the effector and regulatory mechanisms 
of both innate and adaptive immune responses. Neutrophils are the first cells to 
migrate to sites of infection and exhibit a wide range of sophisticated functions 
such as phagocytosis, the release of anti-microbial substances, ROS. Under 
inflammatory conditions and in homeostasis, the activation and survival of 
neutrophils must be tightly controlled because the release of cytotoxic 
substances by neutrophils can easily cause collateral damage of adjacent 
healthy tissue. Since MCs could be a potential candidate in controlling 
neutrophils, the first aim of my study is to investigate and characterize the 
crosstalk between MCs and neutrophils. 
As It has become increasingly evident that MCs and neutrophils have the 
potential to influence the generation and intensity of the adaptive immune 
response the second aim of the work is to focus on the effect of MC-neutrophils 
crosstalk in the regulation of the adaptive immune system, in particular of B 
cells, in a T-independent contest. 
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3. RESULTS 
3.1. MCs induce neutrophils chemotaxis 	  	  
The recruitment of circulating neutrophils to specific sites plays a crucial role in 
a number of physiological and pathophysiological events so neutrophil 
recruitment is an important early step in controlling tissue infection or injury.  
To demonstrate the ability of MCs to induce neutrophil migration, chemotaxis 
assays were performed using bone marrow purified neutrophils and conditioned 
media (CM) of in vitro differentiated MCs. As shown in figure 3.1 CM of 
IgE/DNP and LPS activated wild type (WT) MCs induce migration of 
neutrophils. Using CM obtained from TNFα-deficient MCs the amount of 
migrated neutrophils is diminished but not abrogated. TNFα is a cytokine 
implicated in neutrophils recruitment at inflammatory sites (De Filippo et al., 
2013)  but as shown in this experiment probably it’s not the unique MC-derived 
mediator involved in neutrophil migration. Previous studies suggest positive and 
negative regulatory roles for TNFα signaling during neutrophil motility and 
chemotaxis, and much work suggest that TNFα induces inflammation indirectly 
via the induction of other inflammatory mediators (Lokuta & Huttenlocher, 
2005). Moreover, other MC-derived mediators such as leukotrienes, chymases 
and tryptases are all reported to be important for neutrophil recruitment (De 
Filippo et al., 2013). Therefore, it is possible to speculate that MCs contribute to 
neutrophil recruitment through different pathways. 
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Fig. 3.1: Conditioned media of activated MCs induce neutrophils chemotaxis. Sensitized or not wild 
type (WT) MCs and TNFα-/- MCs were cultured for 24 hours with medium alone or containing different 
stimuli: DNP (100 ng/ml), LPS (1 µg/ml). Conditioned media (CM) were retrieved and used to induce 
neutrophil chemotaxis in a transwell filter diffusion assay. Migrated cells were counted and results (mean + 
standard deviation (s.d) of 3 separated experiments performed in duplicate) are shown as fold induction 
compared to cells migrated in response to non- conditioned media. 
 
 
3.2. MCs activate neutrophils 	  	  
To verify whether MCs can influence neutrophil activation, a co-culture system 
using bone marrow purified neutrophils and in vitro generated MCs has been 
set up. The expression levels of the surface activation markers CD11b and 
CD62L, the degranulation and the vitality of neutrophils were investigated by 
FACS analysis directly in the co-cultures gating on neutrophil population and 
were compared with those of neutrophils cultured alone. 
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 CD11b up-regulation    3.2.1.
 
 
Fig 3.2.1 MCs enhance CD11b expression on neutrophils. A. MCs (not act and act) and neutrophils 
were co-cultured in presence and absence of transwell system (TW) B. MCs (not act and act) from WT 
and Syk-/- mice were co-cultured with neutrophils. C. Neutrophils were cultured with conditioned media 
(CM MC) of activated MCs or with MCs that have been previously activated for 30 minutes, washed and 
then added to the co-culture and re-stimulated with DNP (degr MC). The expression of CD11b on 
neutrophils (identified as FcεRI negative cells) was analyzed at 4 hours. Data (mean + s.d) are from at 
least 5 independent experiments. *p<0,05  
 
CD11b (Mac-1) is a member of the β-integrin family of adhesion proteins that is 
expressed in very low levels on the surface of un-stimulated neutrophils but is 
primarily stored in secretory granules within the cell (Weirich et al., 1998). The 
activation of neutrophils is followed by the rapid translocation and accumulation 
of CD11b to the plasma membrane. To investigate CD11b expression, bone 
marrow purified neutrophils and in vitro differentiated MCs sensitized and not 
with monoclonal ant-DNP IgE were co-cultured in 1:1 ratio. To activate MCs, 
DNP (100ng/ml) was administered directly in the co-culture.  After 4 hours, the 
expression of CD11b on FcεRI negative cells in the co-culture was evaluated by 
FACS analysis. As shown in the figure 3.2.1 MCs, especially once activated, 
induce the up-regulation of CD11b, thus induce neutrophil activation. To 
investigate whether cell contact is necessary for neutrophil activation, cells were 
co-cultured in contact or separated by trans-well membrane (TW). The 
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presence of the TW insert, that physically hinders the contacts between MCs 
and neutrophils, reduces significantly but not prevents the up-regulation of 
CD11b expression. Thus, both cell-cell contacts and soluble factors should be 
implicated in MC-driven activation of neutrophils. In fact, conditioned media of 
activated MCs (figure 3.2.1 C) induce a higher increase of CD11b expression 
respect resting MCs but not at the same level observed in neutrophils in contact 
with activated MCs. This data is further confirmed by the use of MCs lacking the 
Syk tyrosine and therefore MCs that don’t degranulate.  In this case in fact we 
didn’t find neutrophil activation (figure 3.2.1 B).  
The soluble factor responsible of activation is probably an early released 
mediator because when we put in co-culture neutrophils with MCs that were 
previously challenged with DNP for 30 minutes, washed and then re-stimulated 
with DNP, we found a decreased neutrophil activation respect the system with 
fully activated MCs (figure 3.2.1 C). 
A possible candidate for CD11b up-regulation could be TNF-α noted in literature 
to be involved in the regulation of some functions of neutrophils (Montecucco et 
al., 2008). So we co-cultured neutrophils with TNF-/-α activated MCs or with WT 
activated MCs in presence of mAb anti TNFα. As shown in figure 3.2.1.1 TNFα 
has a role in neutrophils activation since in presence of TNFα-/- MCs and in 
presence of mAb anti TNFα we found a reduced increase in CD11b expression.  
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Fig 3.2.1.1 TNFα influences neutrophil activation. 
Neutrophils were incubated with WT or TNF-/- 
activated MCs in presence or absence of mAb anti 
TNFα at a concentration of 10µg/ml. The expression 
of CD11b marker was analyzed by FACS analysis 
after 4 hours of co-culture. Mean+ s.d of at least 3 
independent experiments are shown.	  *p<0,05 
 
Histamine release occurs during the early phase allergic reaction concomitantly 
with neutrophil infiltration. To see if histamine, besides TNFα, can be involved in 
neutrophils-MC crosstalk, two histamine antagonists diphenhydramine and 
thioperamide were added to the co-culture and CD11b expression was 
evaluated after 4 hours. No differences respect the un-treated samples have 
been found, indicating that histamine is not implicated in neutrophil CD11b up-
regulation (figure 3.2.1.2) 
 
 
 
Fig 3.2.1.2 Histamine agonists don’t change 
neutrophil CD11b expression. Neutrophils and 
activated MCs were co-cultured in presence of 10 
µg/ml histamine H1 receptor antagonists 
diphenhydramine (dif) and histamine H4 receptor 
antagonist thioperamide (thio). Data represent the 
mean + s.d of 2 independent experiments. 
 
 
Experiments with TW suggested a crucial role for cell-cell contact in CD11b up-
regulation together with soluble factors. So we decided to carry on the study 
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using different combination of several blocking mAb against surface molecules 
that could be involved in MC-neutrophil interaction. CD18 has been implicated 
in the mediating the intercellular contacts that neutrophils may establish with 
other leukocytes or NK (Costantini et al., 2010). Since MCs express on their 
surface ICAM1 which is a binding receptor of CD18, we incubate neutrophils 
and MCs in presence of neutralizing monoclonal antibodies (mAb) against 
CD18 and ICAM1. We focused also on the SIRP1α/CD47 axis because these 
co-stimulatory molecules are constitutively expressed on MCs and neutrophils 
respectively and on the role of soluble TNFα. As shown in figure 3.2.1.3 the 
block of the CD18/ICAM axis weakly reduces the increase of CD11b expression 
while the block of the SIRP1α/CD47 axis has not effect. The concomitant 
addition of both the mAb against ICAM and the mAb against SIRPα didn’t show 
a further effect. However the addition in the co-culture of both mAb against 
ICAM and mAb against soluble TNFα revealed a synergistic effect in inhibiting 
the up-regulation of CD11b as demonstrated by 20% reduction of the CD11b 
mean fluorescence (mean fluorescence 104±10 versus 80±8). A similar 
reduction was observed by the addition of TNFα blocking antibody in presence 
of TW.  
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 Fig 3.2.1.3 Effect of different monoclonal blocking antibody in neutrophil activation. Neutrophils 
and activated MCs were co-cultured in presence of different neutralizing monoclonal antibody (mAb) at a 
concentration of 10µg/ml. Mean + s.d of at least 3 independent experiments are shown. *p<0,05 
 
Neutrophils recruited at the site of inflammation or infection are probably 
already activated and therefore an important point is to understand if MCs can 
further influence the activation of already activated neutrophils. So we 
incubated neutrophils with suboptimal doses of LPS in presence of WT MCs 
and Myd88-/- MCs. The latter ones lack of the adapter protein used by almost all 
TLRs (including TLR4), so they can’t respond to LPS stimulus. As shown in 
figure 3.2.1.4 the expression of CD11b on neutrophils activated with suboptimal 
amounts of LPS is enhanced by the presence of MCs. This experiment, once 
again, emphasizes the role of MCs in neutrophil activation because it sheds on 
light that MCs can lower the LPS activation threshold of neutrophils making 
them susceptible to respond to suboptimal concentration of LPS. 
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Fig 3.2.1.4 MCs further enhance CD11b expression of LPS-activated neutrophils. Myd88-/- and WT 
MCs activated with IgE/Ag or not were cultured with neutrophils in presence of different concentrations of 
LPS. CD11b expression marker was analyzed at 4 hours by FACS. Data (mean + s.d) are from at least 3 
independent experiments. *p<0,05: **p<0,005 
 
 CD62L down regulation 3.2.2.	  	  
Another activation marker of neutrophils is the adhesion molecule L-selectin  
(CD62L). Resting neutrophils constitutively express high levels of CD62L on 
their surface and their activation is accompanied by a down-regulation of this 
marker by shedding. It interacts with carbohydrate ligands mediating the initial 
rolling of leukocytes on the endothelium (Sengstake, Boneberg, & Illges, 2006). 
Similarly to CD11b analysis, neutrophils were incubated with not activated and 
DNP-activated MCs in presence or absence or TW and CD62L in neutrophils 
has been detected after 30 minutes. 
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Fig 3.2.2 Neutrophil CD62L down-regulation in presence of MCs. A MCs activated or not and 
neutrophils were co-cultured in presence and absence of transwell system (TW). B. WT and Syk-/- MCs, 
activated or not, were co-cultured with neutrophils. Neutrophils surface expression of CD62L was analyzed 
at 30 minutes by FACS gating on GR1 positive cells. Mean + s.d of at least 3 independent experiments are 
shown. *p<0,05 
 
As shown in figure 3.2.2 the presence of activated MCs induces an evident 
decrement of CD62L that is completely prevented when cells are separated by 
TW. The null effect on CD62L expression shown in presence of Syk-/- MCs 
confirm the hypothesis that besides a contact-dependent mechanism, also a 
contribution of early released soluble factors could be involved in MC-induced 
neutrophils activation.  
 
 Activated MCs induce an increase of ROS 3.2.3.
production and lactoferrin degranulation  	  	  
Next, the ability of neutrophils to mediate an oxidative burst in presence of MCs 
was investigated. A resting neutrophil has very little capacity to produce ROS, 
as NADPH oxidase is a multi-component enzyme that is assembled at the 
plasma membrane during priming. To test ROS production neutrophils were 
previously pulsed with CM-H2DCFDA, then incubated with activated and non 
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activated MCs, in presence or absence of TW and the levels of ROS were 
monitored after 30 minutes by FACS. As shown in the figure 3.2.3 panel A, the 
production of ROS in neutrophils is enhanced in the presence of activated MCs 
but nor when cells are separated by TW or when cell-cell contact is prevented 
by the addition of the blocking mAb against CD18 (figure 3.2.3 panel B), 
suggesting once again the importance of the physical interaction in MC-driven 
activation of neutrophils.  
 
 
 
 
Fig 3.2.3 MCs promote neutrophil ROS production. Neutrophils were co-cultured with MCs activated or 
not (A) in presence or absence of TW system or mAb anti-CD18 at 10µg/ml (B). ROS production was 
examined at 30 minutes using H2DC-FDA as described in methods. Data are the mean + s.d of 3 
independent experiments. *p<0,05 
 
Lactoferrin is an iron-binding protein that is released from activated neutrophils 
at sites of inflammation and has anti-microbial as well as anti-inflammatory 
properties. (Wong et al., 2009) The levels of lactoferrin in the supernatants of 
the co-culture were evaluated by ELISA assay and were found higher when 
neutrophils were cultured with activated MCs (figure 3.2.3.1). The pg/ml 
released, however, were not so abundant suggesting that MCs can promote but 
not induce a strong neutrophil degranulation. Again, the addition of mAb anti 
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CD18 seems to prevent neutrophil activation, as shown by the reduced levels of 
lactoferrin (figure 3.2.3.1) in the supernatants. 
 
Fig 3.2.3.1 MCs promote neutrophil 
degranulation. 5x106  /ml neutrophils were co-
cultured for 1 hour with equal number of activated 
or not activated MCs in presence or absence of 
mAb anti CD18 (10µg/ml). Supernatants were 
harvest and lactoferrin levels were measured by 
ELISA. Data are the mean + s.d of 2 independent 
experiments. 	  	  	  
3.3.  Increase of soluble BAFF in neutrophil-MC co-
culture 	  	  
Neutrophils have been “re-discovered” as very versatile cells, contrary to their 
traditional description as terminally differentiated effectors of inflammation. The 
newly discover effector functions of neutrophils are also marked by the fact that 
they represent an important source of several cytokines including BAFF/BLyS. 
BAFF is a member of TNF superfamily of cytokines that exist as a membrane 
protein or as a soluble protein. It’s express mainly, but not exclusively, by cells 
of myeloid origin and plays a fundamental role in B-cell differentiation, 
proliferation and immunoglobulin production.  
Remarkably, the production of neutrophil-derived cytokines can be controlled by 
sophisticated regulatory mechanisms, and the pool of intracellular BAFF 
accumulated in neutrophils can be release in extracellular milieu when 
neutrophils are exposed to pro-inflammatory stimuli like chemokines CXCL1, or 
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eicosanoid (LTB4), cytokines (TNFα) or bacterial product (LPS) that act like 
secretory –like molecules (Scapini, Bazzoni, & Cassatella, 2008). 
As activated MCs can secrete a large array of mediators including those 
responsible of BAFF release, we tested if MCs can control and influence 
neutrophil BAFF production. Supernatant of neutrophil-MC co-culture were 
harvest at 4 and 24 hours and BAFF presence was measured by ELISA.  As 
shown in figure 3.3 MCs seems to enhance BAFF production and it seems also 
to be related to the contact between the two cells as in presence of TW system 
there is a lower presence of soluble BAFF. 
 
 
Fig 3.3 MCs can enhance neutrophil BAFF release. Neutrophils (N) and activated MCs were co-
cultured at ratio 1:1 for 4 and 24 hours with medium containing different stimuli: DNP (100 ng/ml), LPS 
(5µg/ml) and with transwell system (TW). Supernatants were retrieved and used to assess ELISA assay. 
Mean +s.d of 3 independent experiments are shown. *p<0,05. 
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3.4. MCs induce neutrophil death 	  	  
Neutrophils are normally short living cells, but recent studies demonstrate that 
in presence of some cells, like for example bone marrow derived mesenchimal 
stromal cells, they can display a lower tendency to undergo apoptosis 
(Cassatella et al., 2011). To investigate the influence of MCs on neutrophil 
survival, purified neutrophils were plated with MCs either in direct contact or in 
TW condition. Viability of GR-1 positive cells was investigated at 20 hours of 
incubation. As shown in figure 3.4 neutrophil survival was affected by the 
presence of MCs. In fact MCs decrease neutrophil survival by a contact 
dependent mechanism as demonstrated by the employment of TW system: 
when cells are separated neutrophils viability was restored to the resting 
condition.  	  	  
 
 
 
 
 
 
 
 
 
 
 
Fig 3.4 Neutrophil survival is affected by MC presence. Neutrophils were co-cultured with MCs 
(activated or not) in presence or absence of TW for 20h. LPS was used as positive control. The vitality of 
cells was measured by annexin V/ propidum assay by FACS analysis gating on GR-1 positive cells. 
Results (mean + s.d) of at least 3 independent experiments are shown. * p<0,05. 
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Since CD18 has been implicated in MC-induced neutrophil CD11b up-
regulation and ROS production, we evaluated also its role in mediating 
neutrophil survival in presence of MCs. However, the presence of neutralizing 
monoclonal antibody (mAb) against CD18 and ICAM1 did not seem to modify 
neutrophil survival as shown in figure 3.4.1 suggesting that the axis CD18/ICAM 
could not be involved. 
 
 
 
 
Fig 3.4.1 Effect of CD18/ICAM axis in neutrophil 
viability Neutrophils were co-cultured with activated 
MCs in presence of 10µg/m of mAb anti CD18 and 
anti ICAM1. Mean + s.d of 3 independent experiments 
are shown.  
 
 	  	  
3.5. MC and neutrophil phenotype doesn’t change 	  	  
In addition to the capacity to produce and release soluble factors, MCs can 
express several co-stimulatory molecules. Neutrophils, furthermore, have been 
shown to contain many different types of receptors molecule preformed that can 
rapidly translocate to the cell surface providing an immediate change in cells 
phenotype (Sandilands, McCrae, Hill, Perry, & Baxter, 2006). The co-
stimulatory molecules expressed by MCs and neutrophils that could be involved 
in MC-neutrophil interaction were analyzed in co-culture system at 3 and 24 
hours. We focused our attention in some molecules note to have a role in the 
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interaction between immune cells and that are constitutively express on the 
cells of our interest like for example BAFF, CD200R (Gorczynski, 2012), DNAM-
1 or CD226 (Bachelet,Munitz,Mankutad&Levi-Schaffer,2006), GITR (Ronchetti 
et al., 2004), OX40, OX40L (Sibilano et al., 2011) and finally CD40-CD40L 
(Merluzzi et al., 2010). We didn’t find any differences in the expression of these 
molecules in co-culture system neither in neutrophils nor in MCs. Fig 3.5	   
 
 
 
Fig 3.5 No differences in co-stimulatory molecules expression in co-cultures. The presence of 
different receptors in neutrophils (N) and MCs (MC) alone (Black line) or in co-culture (red line) were 
analyzed at 3 hour and 24 hours by FACS analysis gating on GR1 and FcERI positive cells. Results from 
one representative experiment are shown. 
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3.6. Neutrophil influence on MC degranulation 	  	  
MCs are effector cells of immediate hypersensitivity and allergic diseases. 
Cross-linking the high-affinity IgE receptor, FcεRI, initiates the activation of 
MCs, which results in immediate release of a variety of preformed mediators 
including β-hexosaminidase, histamine and TNFα (Carlos et al., 2006). 
As we have firstly investigated how MCs could directly activate neutrophils, the 
reverse effect, that is the effect of neutrophils on MC, was then investigated.  
We co-cultured IgE/Ag activated MCs with alive, necrotic and apoptotic 
neutrophils and compared their activation status with IgE/Ag activated MCs 
cultured alone. Necrotic and apoptotic neutrophils were obtained respectively 
by incubating freshly purified neutrophils at 56°C for 30 minutes or by culturing 
them for 24 hours in medium without serum. Necrosis and apoptosis were 
monitored using Annexin V/ propidium assay.  To test MC degranulation the 
expression of Lysosomal-associated membrane protein 1 (LAMP1) on FcεRI 
positive cells in the MC-neutrophil co-culture was analyzed. LAMP1 also known 
as CD107a, is a glycoprotein marker of degranulation on MCs, lymphocytes 
and NK. As degranulation occurs, secretory lysosome are released, and 
LAMP1 is transported to the surface of cells rendering accessible for antibody 
binding (Aktas, Kucuksezer, Bilgic, Erten, & Deniz, 2009). As shown in figure 
3.6 apoptotic, necrotic, resting neutrophils or their conditioned media don’t 
influence MC degranulation. 
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Fig 3.6 MC degranulation is not influenced by resting, apoptotic and necrotic neutrophil presence. 
MCs activated (act) or not (unst) were co cultured for 30 minutes with: A resting (N), apoptotic (APO N) 
neutrophils and their conditioned media (CM); B resting (N) and necrotic (NEC N) neutrophils and their 
conditioned media. LAMP1 expression, on FcεRI positive cells, was analyzed by FACS. Data (mean +s.d) 
of at least 3 independent experiments are shown. 
 
However, co-culturing activated MCs with LPS activated neutrophils, with 
conditioned media of LPS activated neutrophils and with neutrophils pre-
incubated with LPS for 1 hour, the percentage of LAMP positive cells were 
reduced. We used Myd88-/- MC to be sure to exclude the effect of LPS on MCs 
(figure 3.6.1) Thus activated neutrophils, but not resting, apoptotic or necrotic, 
seem to down-regulate MC degranulation. 	  	  
Fig 3.6.1 LPS-activated neutrophils decrease MC 
LAMP1 expression. IgE/Ag activated Myd88-/- MCs 
were co-cultured 30 minutes in presence of 
neutrophils, neutrophils activated with LPS 5µg/ml, 
24 hours conditioned medium (CM) of neutrophils 
activated with LPS (act N) and with neutrophils pre-
activated (pre-act) with LPS for 1 hour. LAMP 1 expression, on FcεRI positive cells, was analyzed by 
FACS. Mean + s.d of 2 independent experiments are shown. 
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3.7. Levels of cytokines in neutrophil-MC co-culture 	  	  
MCs are known to secrete a large array of mediators in response to different 
stimuli. To evaluate the behavior of MCs in presence of neutrophils, 
supernatants of the co-cultures were harvested at different time points and the 
presence of some of the most important cytokines produced by MCs and 
implicated in neutrophils functions was measured by ELISA (figure 3.7 A, C, E). 
To better analyze the production of two of them, IL6 and TNFα, an intracellular 
staining was also preformed (figure 3.7 B, D). As shown in fig 3.7 A in MC-
neutrophil co-culture there is a decrease of TNFα at 3 hours and 24 hours in the 
supernatants. It was not dependent on the contact between the two cells 
because using TW system or mAb anti CD18 we haven’t found any differences. 
Deepening this data by intracellular staining (figure 3.7 B) we found that there is 
no difference in TNFα production between MCs alone or in co-culture with 
neutrophils. Thus, the diminished levels of TNFα in the co-cultures don’t depend 
on an inhibitory effect of neutrophils in MC production, but probably it suggests 
that neutrophils consume the TNFα produced and released by MCs.	   
Regarding IL6 and TGF-β secretion we haven’t found any differences between 
the co-culture and single cells system (figure 3.7 C, D, E). 
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Fig 3.7 Cytokines production and release in MC-neutrophil co-cultures. A.C.E activated MCs and 
neutrophils (N) were co-cultured at ratio 1:1 for 24 and 3 hours (A) with medium containing different 
stimuli: DNP (100 ng/ml), LPS (5µg/ml), mAb anti CD18 (10µg/ml), and with transwell system (TW). 
Supernatants were retrieved and used to assess ELISA assay . B.D Intracellular staining: neutrophils (N) 
and MCs were co- cultured at ratio 1:1 in presence or not of DNP (100ng/ml). After 12h of incubation with 
brefeldin A intracellular staining assay was perform. Data were analyzed by FACS. Results (mean + s.d) of 
at least 5 independent experiments are shown. *p<0,0 
 
3.8. Effect of MC-Neutrophil crosstalk on B cells 	  	  
Recent studies shown that MCs promote both survival and activation of B cells 
as well as proliferation and further plasma cells differentiation of activated B 
cells through cell-cell contact and soluble factors (Merluzzi et al., 2010). Latterly 
also neutrophils role has been challenge. Numerous studies have shown that 
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neutrophils mediate also diverse immune functions by releasing preformed and 
newly synthetized mediators that can regulate recruitment and activation of 
other cells including B cells. On the basis of these evidences we decided to 
study the effect of MC-neutrophil interaction in the activation of adaptive 
immunity, namely B cells. The viability of freshly purified splenic B cells 
incubated with conditioned medium derived from MCs, neutrophils and MC-
neutrophil co-culture was investigated. As shown in figure 3.8 conditioned 
media of neutrophils, of activated MCs and more clearly of neutrophil-MC co-
culture enhanced B cell survival (figure 3.8). 
 
 
Fig 3.8 Conditioned media of neutrophils and 
activated MCs enhance B cell survival. 
IgE/DNP activated MCs and neutrophils alone or 
at 1:1 ratio were co-cultured for 24 hours. 
Supernatants were retrieved and used to assess 
B cells survival assay. Annexin V/propidium assay 
was used to test B cell vitality. Data were 
analyzed by FACS. The mean + s.d of 3 
independent experiments are shown. *p<0,05 
 
 
In the same supernatants the levels of cytokines known to be involved in B cells 
survival like BAFF, IL6 and TGFβ were also measured. Only BAFF was 
increased in supernatants (harvested at 4 and 24 hours) from activated MC-
neutrophil co-culture (figure 3.8.1 A). This is a very important point because 
previous studies revealed that soluble BAFF released by neutrophils was found 
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to be biologically active and to prolong survival of murine splenocytes (Scapini 
et al., 2008). 
 
	  
Fig 3.8.1 Increase of BAFF in supernatants of neutrophil-MC co-culture. A, B, C activated MCs and 
neutrophils were co-cultured at ratio 1:1 in medium containing different stimuli. Supernatants were 
retrieved and used to assess ELISA assay. A IgE/DNP activated MCs and neutrophils were co-cultured for 
4 and 24 hours in medium containing different stimuli: DNP (100 ng/ml), LPS (5µg/ml). B, C IgE/Ag 
activated MCs and neutrophils were co-cultured for 24 hours in presence of different stimuli DNP (100 
ng/ml), LPS (5µg/ml). Data (mean + s.d) of at least 5 independent experiments are shown. *p<0,05 
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3.9. KitW-sh/W-sh mice as a mouse model to investigate MC-
neutrophil relationship 	  	  
C57BL/6 KitW-sh/W-sh mice, bearing the W-sash (wsh or Wsh) inversion mutation, 
have MC deficiency in all tissues but normal levels of major classes of other 
differentiated hematopoietic and lymphoid cells. Compared to other MC-
deficient mouse strain, KitW-sh/W-sh mice are experimentally advantageous 
because of their background strain and fertility. In these mice, local 
reconstitution of MC population can be achieved by intra-peritoneal (i.p) 
injection of wild-type bone marrow-derived cultured MCs. For these reason, 
they represent a useful model in MC research, especially for analyzing MC 
function in vivo. (Grimbaldeston et al., 2005) However, KitW-sh/W-sh exhibit 
splenomegaly with expanded myeloid and megakaryocyte populations. 
Moreover, hematopoietic abnormalities extend to the bone marrow and are 
reflected by neutrophilia and thrombocytosis (Nigrovic et al., 2008) but there are 
no data correlating the increase of neutrophils with the deficiency of MCs in 
KitW-sh/W-sh mice.  
In our hand KitW-sh/W-sh represents a good animal model to investigate in vivo the 
role of MCs and neutrophils alone or in combination in the regulation of the 
immune system response. In fact KitW-sh/W-sh is a mouse with high number of 
neutrophils but lacking MCs. The injection of bone marrow derived MC 
restablish normal levels of tissue MC and could shed in light the effect of MC on 
neutrophil levels. In addition, the depletion of neutrophils in these three types of 
mice could consent to understand the reciprocal role of MCs and neutrophils in 
influencing the immune response. 
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 Characterization of neutrophils in KitW-sh/W-sh 3.9.1.
mice 	  
Spleen, lymph nodes, bone marrow and blood isolated from C57BL/6 mice, 
KitW-sh/W-sh mice, and MC-reconstituted KitW-sh/W-sh mice were stained for two 
markers of neutrophil identification, CD11b/Ly6G. As shown in figure 3.9.1 
neutrophilia was strongly present in all secondary lymphoid organs of KitW-sh/W-sh 
mice respect of C57BL/6 mice and only weakly in the bone marrow. However, 
surprisingly, in intra-peritoneally reconstituted KitW-sh/W-sh mice neutrophilia is 
reduced. The effect was evident and statistically significant in secondary 
lymphoid organs, spleen and lymph nodes, while fewer differences were found 
in blood and bone marrow. This experiment indicates that the presence of MCs 
in peripheral tissues controls someway the basal levels of neutrophils. 	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Fig 3.9.1	  Neutrophils in C57BL/6, KitW-sh/W-sh (wsh) and reconstituted KitW-sh/W-sh (rec Wsh ) mice. 
Cell suspension from spleen, lymph nodes, bone marrow (BM), blood, peritoneum, were isolated, stained 
for  CD11b and antiLy6G and analyzed by FACS . A: Graph representing the percentage of total Ly6G 
high and CD11b positive cells of at least 3 independent experiments. B Representative dot plots of Ly6G 
high/CD11b positive cells in different organs. **p<0,005 *p<0,05	  	  
To test if neutrophils from KitW-sh/W-sh and C57BL/6 mice have the same 
characteristic, we focused our attention on neutrophils size and granularity and 
Spleen 
B6 WSH REC WSH 
BM 
Blood 
Peritoneum 
Lymph nodes 
CD11b 
Ly
6G
  
100 101 102 103 104
FL1-H
100
101
102
103
104
FL
3-
H
0.94
0,94 % 
100 101 102 103 104
FL1-H
100
101
102
103
104
FL
3-
H
3.56
3,56 % 
100 101 102 103 104
FL1-H
100
101
102
103
104
FL
3-
H
1.5
1,5 %    
100 101 102 103 104
FL1-H
100
101
102
103
104
FL
3-
H
18.4
18,4 % 
100 101 102 103 104
FL1-H
100
101
102
103
104
FL
3-
H
35.7
35,7 % 
100 101 102 103 104
FL1-H
100
101
102
103
104
FL
3-
H
34.7
34,7 % 
100 101 102 103 104
FL3-H
100
101
102
103
104
FL
1-
H
0.51
0,51 % 
100 101 102 103 104
FL3-H
100
101
102
103
104
FL
1-
H
1.2
1,2 % 
100 101 102 103 104
FL3-H
100
101
102
103
104
FL
1-
H
0.23
0,23 % 
100 101 102 103 104
FL1-H
100
101
102
103
104
FL
3-
H
0.034
0,034 % 
100 101 102 103 104
FL3-H
100
101
102
103
104
FL
1-
H
9.99e-3
0,01 % 
100 101 102 103 104
FL3-H
100
101
102
103
104
FL
1-
H
0.29
0,29 % 
100 101 102 103 104
FL3-H
100
101
102
103
104
FL
1-
H
0.17
0,17 % 
100 101 102 103 104
FL1-H
100
101
102
103
104
FL
3-
H
0.09
0,09 % 
100 101 102 103 104
FL1-H
100
101
102
103
104
FL
3-
H
4.48
4,48 % 
B. 
Results	  
	   60	  
GR1-CD11b expression. We haven’t found any differences between neutrophils 
of the two mice neither in morphology nor in GR1 CD11b expression (figure 
3.9.1.1 A; B). 
 
 
 
Fig 3.9.1.1 There are no morphological and CD11b/GR1 expression differences in C57BL/6 and 
KitW-sh/W-sh mice neutrophils. A. KitW-sh/W-sh (wsh) and C57BL/6 (B6) bone marrow neutrophils 
morphology. B. GR1-CD11b expression in KitW-sh/W-sh (wsh) and C57BL/6 (B6) blood neutrophils. GR1-
CD11b expression was analyzed using anti CD11b and anti GR1 antibodies. Representative data of one of 
at least 3 experiments are shown. 
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To exclude that kit mutation in KitW-sh/W-sh mice could affect the life span of 
neutrophil we also compared the vitality of neutrophils isolated from C57BL/6 
and KitW-sh/W-sh mice. We cultured neutrophils in medium containing 10% of 
serum and in medium without serum. No differences in number of viable 
neutrophils was noted at indicated time points either in complete media or 
under pro-apoptotic condition. This suggests that cell survival in KitW-sh/W-sh mice 
is not affected. (figure 3.9.1.2) 
	  
	  
 
Fig 3.9.1.2 No differences in frequency of viable neutrophils between C57BL/6 and KitW-sh/W-sh mice. 
Frequency of viable neutrophils (PI-negative, annexin V negative) in C57BL/6 (B6) and KitW-sh/W-sh (wsh) 
mice were obtained annexin V/propidium staining in media containing 10% of serum and in media without 
serum at different time point from their isolation. Data (mean + s.d) of at least 3 independent experiments 
are shown. 
 
Finally, to verify whether the activation of neutrophils could be differently 
modulated in KitW-sh/W-sh mice, we analyzed the expression levels of the surface 
antigens CD11b and CD62L, in presence or absence of MCs. As shown in 
figure 3.9.1.3 the expression of CD11b and CD62L was significantly up-
modulated and down-modulated respectively under co-culture with MCs. 
Neutrophils from KitW-sh/W-sh mice respond to MC activation following the same 
trend of C57BL/6 neutrophils. 	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Fig 3.9.1.3 C57BL6 and KitW-sh/W-sh mice neutrophils respond to MC activation following the same 
trend. Activated or not MCs and C57BL/6 (B6) or KitW-sh/W-sh (Wsh) neutrophils were co-cultured in 
presence and absence of trans well system (TW) and with different stimuli DNP (100ng/ml), LPS (5µ/ml). 
Neutrophils surface expression of CD11b was analyzed at 4 hours using anti CD11b antibody (A) and 
CD62L was analyzed at 30 minutes using antiCD62L antibody (B) by FACS. Mean + s.d of at least 3 
independent experiments are shown. *p<0,05 
 
 Characterization of B cell population of KitW-3.9.2.
sh/W-sh mice 	  	  
One of the aims of the study is to define the effect of neutrophils-MCs crosstalk 
in the activation of B cells. To do this, we wanted to take advantage of the KitW-
sh/W-sh mice model because these mice are mice lacking MCs and with a strong 
neutrophilia while reconstituted mice almost display the WT background. First of 
all we needed to verify if B cells levels were the same in the three different 
mice. As shown in figure 3.9.2 both KitW-sh/W-sh mice and reconstituted KitW-sh/W-sh 
mice displayed normal levels of CD19+ cells in spleen and peritoneum in fact 
CD45+CD19+ cells population in the spleen and in the peritoneum was 
comparable in the three groups of mice (figure 3.9.2 A, B). The levels of naïve 
(CD45+CD19+CD23-CD21-), B2 (CD45+CD19+CD23+CD21+), MZ 
(CD45+CD19+CD23-CD21+) B cells and plasma-cells (CD138+) in spleen and 
B1a (CD45+CD19+CD5+CD11b+), B1b (CD45+CD19+CD5-CD11b+) and B2 
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(CD45+CD19+CD5-CD11b-) in peritoneum were the same in CD19+ cells 
population of the three mice. This is a very important starting point that permits 
us to going on with the study focusing our attention only in the effect of 
neutrophil-MC-B cell crosstalk as the starting B cell population is the same in 
the different mice. 
 
 
Fig 3.9.2 Characterization of B cell populations in KitW-sh/W-sh. A,B Levels of CD19+ viable cells in 
C57BL/6 (B6), KitW-sh/W-sh (Wsh) and KitW-sh/W-sh reconstituted mice (rec Wsh) respectively in spleen and 
peritoneum of at least 3 independent experiments are shown. C. Mean + s.d of percentage of 
CD19+CD45+ : Naïve (CD23-CD21-), B2 (CD23+CD21+), MZ (CD23-CD21+) B cells and plasma-cells 
(CD138+) in spleen  of at least 3 independent experiments are shown D.  Mean + s.d of percentage of 
CD19+CD45+: B1a (CD5+CD11b+), B1b (CD5-CD11b+) and B2 (CD5-CD11b-)  B cells population in 
peritoneum of at least 3 independent experiments are shown.  
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  T-independent immunization 3.9.3.	  	  
To elucidate the contribution of MCs and neutrophils in the humoral immunity in 
vivo, mice were immunized with TNP-AECM-FICOLL and the serum levels of 
specific anti-TNP immunoglobulin (anti-TNP IgM, IgG3 and IgA) were evaluated 
8 days after. TNP-AECM-FICOLL is a high molecular weight polysaccharide 
useful as T-independent antigen for studying B cells activation. We performed 
the experiment using C57BL/6 WT mice, KitW-sh/W-sh, KitW-sh/W-sh reconstituted via 
i.p with BMMCs, and the same groups of mice depleted for neutrophils.	  
Depletion was carried on, as described in methods, by injecting i.p the anti-
granulocyte receptor-1 (GR-1) mAb and (clone1A8) or the Isotype of control 
(clone 2A3) every other days figure 3.9.3. 
 
 
 
Fig 3.9.3 Representative scheme of depletion and immunization experiment. At T0 mice were 
depleted for neutrophils injecting i.p anti-GR1 mAb or isotype of control (D), the following day (T1) mice 
were immunized (I) with TNP-AECM Ficoll. Depletion (D) was carried on every other day for 8 days. At day 
8 the experiments (EXP) were performed. Blood, peritoneal cells and splenocytes were collected and used 
for different staining. Blood was also use to obtain serum for Ig detection. 
 
We first analyzed if B cells subsets in different mice change after immunization. 
We selected CD45+ CD19+ cells and then we analyzed the expression of CD5, 
CD11b, CD21, CD23. As shown in figure 3.9.3.1 the different B cell populations 
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(B1a, B1b and B2 in peritoneum and naïve MZ B2 in spleen) were comparable 
among different mice after immunization. Also the percentage of plasma-cells in 
blood and spleen was comparable among mice. 
 
 
 
Fig 3.9.3.1	  Characterization of B cell populations after T-independent immunization. Eight days after 
immunization CD45+CD19+ viable cells of peritoneum and spleen in C57BL/6 (B6), KitW-sh/W-sh (Wsh), KitW-
sh/W-sh reconstituted mice (Wsh Rec) and the same group of mice depleted for neutrophils (Dep) were 
selected. Cells were then analyzed for their expression for CD5, CD11b, CD21, CD23 and data reported in 
graph are of two independent experiments. Percentage of CD138+ cells in blood and spleen analyzed from 
2 independent experiments. 
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Then, the levels of specific anti TNP-Ficoll immunoglobulins (Ig) IgM, IgG3 and 
IgA in the serum of mice collected 8 days after immunization were analyzed 
(figure 3.9.3.2). 
TI-immunization resulted in increased production of IgM and IgG3 in KitW-sh/W-sh 
mice, both reconstituted and not reconstituted respect to C57BL/6 mice, and Ig 
levels were also higher in all mice that have been depleted of the neutrophil 
pool. 
Regarding IgA production, there are no significant differences between 
C57BL/6 WT mice, KitW-sh/W-sh mice, and MC-reconstituted KitW-sh/W-sh mice. 
However, depletion of neutrophils clearly increases IgA production especially in 
KitW-sh/W-sh mice. 
 
	  
Fig 3.9.3.2 Ig presence in sera of T-independent immunized mice. Sera were separate from blood after 
8 days after of immunization and specific Igs levels were analyzed by ELISA assay. Data reported are 
from 2 independent experiments. 
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4. DISCUSSION and CONCLUSION  
MCs are pivotal in innate immunity and play important role in amplifying 
adaptive immunity (Alvarez-Errico et al., 2009). They are strategically localized 
along the microvasculature in tissues in close contact with external 
environment, such as skin, lung and intestine. By releasing their pro-
inflammatory mediators, they can influence various aspects of the biology of 
dendritic cells, T cells and B cells thus acting like regulatory cells (Merluzzi et 
al., 2010). MCs have a critical role also in the initiation of acute inflammatory 
responses where they are able to induce neutrophils recruitment. Neutrophils 
are phagocytic cells that act as the first line of defense against infectious 
pathogens in inflammatory response. In addition to their crucial role in 
protecting against infections, recent evidence suggests that neutrophils are also 
key components of the effector and regulatory mechanisms of both innate and 
adaptive immune responses. Their potency and ability to interact with other 
immune cells involve neutrophils in immune defense and also in several 
immune-mediated disease, such as anaphylaxis, metabolic disease, 
autoimmunity and tumor biology (Mócsai, 2013). The control of neutrophil 
activation is therefore highly relevant for all inflammatory conditions and tissue 
resident MCs, known to be involved in the regulation of all phases of the 
inflammatory response, could be good candidates in controlling neutrophil 
functions. The idea that MCs could have a role not only in the recruitment but 
also in the regulation of neutrophil function has been only recently formulated. 
In a paper published in 2013, Doener and colleagues investigated for the first 
time the effect of the presence of MCs on the in vitro activation of freshly 
isolated neutrophils, demonstrating the capacity of MCs to induce up-regulation 
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of neutrophil surface markers, production of ROS and enhancement of 
phagocytosis (Doener et al 2013). In that work the authors incubated 
neutrophils with MCs or with conditioned media of IgE/DNP activated MCs and 
found the same impact on neutrophil effector functions. These results led the 
authors to speculate that the MC-dependent activation of neutrophils relies on 
soluble factors released by MCs. The work of this PhD thesis, instead, revealed 
that, in addition to soluble factors, the contact between the two cells is 
fundamental. By incubating neutrophils with CM of activated MCs we found an 
increase of neutrophil activation, confirming that soluble factors are involved in 
the effect, but CD11b up-regulation was less marked respect the increased 
expression found when neutrophils were co-cultured with activated MCs. The 
use of tans-well in the co-culture system almost reported neutrophil activation 
(studied on their up regulation of CD11b and down regulation of CD62L 
membrane marker, ROS production, degranulation and vitality) at levels of 
neutrophils cultured alone, suggesting the importance of cell-cell contact in MC-
induced activation. Based on of these evidences we focused our attention on 
the possible molecules involved in the crosstalk and we found an important role 
for the CD18/ICAM axis in ROS production and less obviously in lactoferrin 
degranulation. Furthermore, incubating neutrophils with activated MCs but 
deprived of their early released mediators neutrophil activation was found less 
evident indicating a crucial role for soluble factors immediately released by MC. 
Using BMMCs from TNFα deficient mice we confirmed a crucial role for pre-
stored and early released TNFα in up-regulation of neutrophil CD11b 
expression. Moreover, interestingly, we found that the presence of MCs can 
also lower the activation threshold of neutrophils making them susceptible to 
respond to suboptimal concentration of LPS. 
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On the other hand we described for the first time that neutrophils can affect 
some of the MC activities. Resting, apoptotic or necrotic neutrophils don’t have 
any effect on MC degranulation but, interestingly, LPS-activated neutrophils 
reduce MC IgE/Ag dependent degranulation of MCs. As MCs are known to 
secrete a large array of mediators in response to different stimuli we tested if 
neutrophils can influence cytokine production. Intracellular staining and ELISA 
assays for TNFα, IL6 and TGFβ demonstrated that the presence of neutrophils 
doesn’t affect MC cytokine production. However, the levels of TNFα in the co-
culture system are reduced. Since TNFα is crucial for some neutrophils 
activities (Lokuta & Huttenlocher, 2005) we can speculate that neutrophils 
consume the TNFα that is produced and released by MCs diminishing the 
amount of the TNFα present in the co-culture. All these findings indicate that 
MCs and neutrophils interact each other and that their crosstalk is bidirectional 
and influence mutually the response of both partners. 
 
MCs and neutrophils are involved in physiological and pathological immune 
responses acting at the interface between the innate and adaptive branches of 
the immune system in particular of B cells. As note in literature MCs can induce 
both survival and proliferation of primary naïve B cells and proliferation and 
further differentiation of activated B cells into IgA-secreting plasma cells by cell-
cell contact and through soluble factors (Merluzzi et al., 2010). On the other 
hand activated neutrophils express the B cell activating factor cytokine BAFF 
and are a major source of the BAFF-related B cell-stimulating cytokine APRIL 
that strongly modulate B cell function. In mice splenic neutrophils are 
demonstrated to be able to activate marginal zone B cells, inducing B cell 
survival, antibody production, IgG and IgA class switching and somatic 
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hypermutation (Puga et al., 2012). Taken together these studies have led us to 
further investigate if MCs and neutrophils together had an additional role or 
collaborated in the activation of B response. We reported that supernatants of 
neutrophils and activated MCs co-culture further enhance B cells vitality respect 
to supernatants from neutrophils or MCs cultured alone. This augmented vitality 
correlates positively with increased levels of BAFF in the co-culture 
supernatants. Thus the presence of activated-MCs induces neutrophils to 
increase BAFF production that consequently could enhance B cell survival. 
 
To investigate the role of neutrophil and MC crosstalk on B cell response in vivo 
we have decided to perform T-independent immunization experiments using the 
Kit W-sh/W-sh mice. We take advantage of this mouse strain because it exhibits 
profound MC deficiency concomitantly to a strong neutrophilia (Nigrovic et al., 
2008) and because MC population can be restored after i.p injection of mature 
BMMCs. The staining of neutrophils (identified as CD11bHigh/Ly6GHigh cells) in 
primary and secondary lymphoid organs of Kit W-sh/W-sh and reconstituted  Kit W-
sh/W-sh mice confirmed the neutrophilia in all secondary lymphoid organs of Kit W-
sh/W-sh mice and, surprisingly, pointed out a reduced neutrophilia when mice 
were reconstituted with in vitro differentiated MCs. There aren’t apparently 
differences between neutrophils from C57BL/6 and Kit W-sh/W-sh mice because 
they show the same vitality and the same ability to respond to MC-induced 
activation. However, the reduction of neutrophilia in reconstituted Kit W-sh/W-sh 
mice suggests that MCs someway can control the levels of neutrophils in 
peripheral lymphoid organs.  
The experiments of T-independent immunization performed in the three 
different groups of mice (C57BL6, Kit W-sh/W-sh, and Kit W-sh/W-sh reconstituted with 
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in vitro differentiated MCs) depleted or not for neutrophils, indicated important 
role for neutrophils and MCs in Ig production from B cells. The depletion of 
neutrophils in C57BL/6 depleted mice correlates with increased level Ig in 
serum suggesting a suppressive role of neutrophil in B cell immunoglobulin 
production. These results contrast with Cerutti’s findings, because he 
demonstrated that a splenic population of neutrophils defined B helper (NBH), 
phenotypically and functionally distinct from circulating neutrophils, gives to MZ 
B cells signals to produce IgM as well as class-switched IgG and IgA antibodies 
(Cerutti et al., 2013). In his work, the group identified innate lymphoid cells 
(ILCs) in MZ and peri-follicular zone of the spleen. They found that these cells, 
in addition to stimulating MZ B cells and plasma cells via BAFF, APRIL, CD40L 
and Notch2 ligand Delta-like 1 (DLL1), communicate with MZ B cells-helper 
neutrophils (NBH) via the cytokine GM-CSF. They found that incubating 
neutrophils with ILCs conditioned medium, they up-regulated APRIL expression 
and stimulated IgA production in MZ B cells in vitro. In vivo they saw that in 
ILCs-deficient mice, impaired production of IgG3 was associated with fewer NBH 
cells. Furthermore, our results are interesting in light of recent report from Jee  
that demonstrated a suppressive role of neutrophils in IgA production. In vitro, 
co-culturing B cells with neutrophils, Jee and colleagues found a significantly 
reduced IgA heavy chain transcript in B cells and a reduced secretion of IgA. 
This was also confirmed by in vivo experiments where they demonstrated that 
depletion of Ly6G+ cells improves the development of IgA responses after 
sublingual immunization with Bacillus anthracis edema toxin. Thus both our 
data and data from Jee’ s group suggest a suppressive role for neutrophil in in 
vivo Ig production. 
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However Kit W-sh/W-sh mice displayed increased levels of Ig despite their 
neutrophilia and lack of MCs. The lack of both neutrophils and MCs in depleted 
Kit W-sh/W-sh mice results in a further augment of Ig production that are lowered 
following MC reconstitution. The explanation of these results should kept in 
account the recent findings from Michael and colleagues who demonstrated 
that the deregulation of c-Kit expression in Kit W-sh/W-sh mice causes 
accumulation in the spleen of CD11b+/Ly6Gint-high Ly6C+ cells which resemble 
granulocytic myeloid derived suppressor cells.  So to understand the effect of 
MC deficiency and neutrophilia further experiments must be performed to better 
characterize and comparing GR1+ cells subpopulation in C57BL6 and Kit W-sh/W-
sh mice to verify if different subpopulations can differently influence B cell 
response. 
 
Taken together results from the thesis underline that neutrophils and MCs 
physically interact and this interaction brings to neutrophils activation and down-
regulation of some MC functions. Since IgA, IgM and IgG3 production by B 
cells, MC degranulation and the presence of some of MC soluble factors seem 
to be impaired by the presence of neutrophils It can be supposed that probably 
neutrophils could limit MC-B cell interaction (figure 4). Hence, a regulating role 
of neutrophils in B cell Ig secretion was put on light but it must be further 
investigated.  
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Fig.4 Schematic representation of neutrophil-MC interaction in B cell activation.  It was possible to 
speculate that: MCs can activate neutrophils (1), activated neutrophils can reduce MC response (2) so 
they can limit MC-B cell interaction (3), and can interact directly with B cells (4) (like suppressor cells for 
example). 	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5. METHODS 
5.1. Mice  	  	  
C57BL/6 mice were purchased from Harlan Laboratories (Harlan Italy); 
C57BL/6 TNFα, and MC-deficient C57BL/6-KitW-sh/W-sh mice (wsh) were kindly 
provided by Dr. M. Colombo (Fondazione IRCCS Istituto Nazionale dei Tumori 
di Milano). C57BL/6 Myd88-deficient mice and C57BL/6 Syk-deficient mice 
were kindly provided by Dr Cassatella (University of Verona).  
 
5.2. Isolation of murine Neutrophils 	  	  
Neutrophils were isolated from bone marrow by positive selection magnetic cell 
separation (MACS) using the mouse Anti LY6G MicroBead Kit (Miltenyi Biotec). 
The purity of the isolated cell was at least 97% according to the expression of 
Gr-1 and CD11b (figure 5.2). Neutrophils receptors expression was determined 
by flow cytometry using fluorochrome-conjugated monoclonal antibodies. 
After the dissection of femur and tibia, the tissue was cleaned and the ends of 
bone were cut as marrow could be visible. With 23G needle and 10 ml syringe 
cells were flush out in 50 ml falcon tube, until bones appear white. After 
centrifugation at RT at 1500 rpm, 5 minutes 6 ml of 0,2% of NaCl solution for 30 
seconds and then 14 ml of 1,2% of NaCl solution were added to allow osmotic 
lysis of red blood cells. Cells were passed through 70 µm strainer and collected 
at 1500 rpm 5 minutes at RT. After centrifugation the obtained cellular 
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suspension was re-suspended in MIN Buffer (a solution containing PBS, 0,5% 
BSA, 2mM EDTA) and spinned at 1300 rpm 10 minutes. 
Then the pellet was re-suspended in 250µL of MIN buffer per 108 cells 
containing Anti-Ly-6G Biotin (50µL for 10 minutes at 4°C). After 10 minutes 150 
µl of buffer per 108cells and anti Biotin micro Beads (100 µl for 15 minutes at 
4°C) were added. Washed cells were re-suspended in 500µL of buffer. Anti- 
Ly6G-Biotin and anti-Biotin Micro Beads magnetic labeled Gr-1high Ly-6G+ PMN 
were positive selected through magnetic separation. Magnetic purification was 
performed in a Miltenyi Biotech LS column, placed in the magnetic field of a 
MACS separator. Cell suspension was applied onto the column and the flow-
through containing unlabeled cells, that represent the pre-enriched Gr-1dim Ly-
6G– fraction, was collected. After removing from separator, the magnetically 
labeled PMN were flushed out by pushing the plunger into the column. After a 
second passage in column of the eluted fraction to increase the purity of LY-
6G+ cells, PMN were re-suspend in RPMI medium supplemented with 10% 
FCS, 2 mM L-glutamine, 200 U penicillin, and 200 mg/ml streptomycin. 
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Fig 5.2 Purity of	   the bone marrow-derived neutrophils. Representative example of FACS analysis to 
evaluate neutrophils purity. Neutrophils gated on the basis of their size and granularity (FSC vs SSC plot, 
left side), are positively stained for both CD11b and GR1 (right panel). 
 
5.3. Differentiation of BMMC in vitro 	  	  
Bone marrow-derived MCs (BMMCs) were obtained by in vitro differentiation of 
bone marrow cells taken from murine femur. Bone marrow precursors were 
cultured in RPMI 1640 medium supplemented with 20% FCS, 2 mM L-
glutamine, 100U/ml penicillin, 100 µg/ml streptomycin, nonessential amino 
acids, sodium pyruvate, HEPES buffer, 50mM β-mercaptoethanol and 
containing 20 ng/ml stem cell factor (SCF) and 20 ng/ml IL-3 for 4 to 8 wk. All 
cell cultures were grown at 37°C in a humidified atmosphere with 5% CO2. 
After 4-5 weeks, BMMCs were monitored for FcεRI (Biolegend) and ckit 
(Biolegend) expression by flow cytometry with purity usually more than 95% 
Figure 5.3). 
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For IgE dependent activation, BMMC were sensitized in medium (RPMI 10% 
FCS) without IL3 for 3 hours with 1µg/ml of dinitrophenol (DNP)-specific IgE 
washed and then challenged with 100 ng/ml DNP (Sigma-Aldrich) 
 
 
Fig 5.3 Purity of	  the bone marrow-derived mast cells (BMMC) population. Representative example of 
FACS analysis to evaluate BMMC maturation. Mature BMMCs, gated on the basis of their size and 
granularity (FSC vs SSC plot, left side), are positively stained for both FcεRI and c-Kit (right panel). 
 
5.4. Purification of murine B cells 	  	  
Splenic B cells were obtained from 6-12 week-old mice by negative depletion. 
Spleens were dissociated in PBS / sodium citrate (0,0192M) and pellet after 
centrifugation at 1800 rmp 5 minutes. Red blood cells were lysed using ACK 
lysis buffer (Sigma Aldrich) 2 minutes at room temperature. Splenocytes 
suspension was depleted of T cells by complement-mediated cytotoxic lysis 
using and anti-Thy 1.2 monoclonal antibody 40 minutes at room temperature (a 
gift from K.Hatcock, Experimental Immunology Branch NIC/NHI), in conjunction 
with rabbit complement (Cedar Lane) 30 minutes at 37°C. The cell suspension 
was then cultured for at least one hour at 37°C and 5% CO2 to allow the 
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adhesion of mononuclear cells at the flask. Cells in suspension were collected 
and re-suspended in RPMI 1640 medium supplemented with 10% FCS, 2 mM 
L-glutamine, 100U/ml penicillin, 100 µg/ml streptomycin, nonessential amino 
acids, sodium pyruvate, HEPES buffer, 50mM β-mercaptoethanol at 106 cell/ml.  
The purity of the isolated cell was between 85-95% according to the expression 
CD19 (figure 5.4). 
 
 
 
 
 
 
 
 
 
 
Fig. 5.4 Purity of	   B cell population isolated from mouse spleen. Representative example of FACS 
analysis to evaluate B cell purity. On the left side B cells are shown gated on the basis of their size and 
granularity (FSC vs SSC plot). The hystograms reported on the right side of the picture show how the 
great majority of the isolated lymphocytes (87,3%) are B cells  and that T cell contamination is only 5,36%  
of total cells. 
 
5.5. Co-Colture  	  	  
Cells were co-coltured in a ratio of 1:1 (2x106 cells/ml), in complete RMPI 
medium without IL3. Different stimuli and blocking antiobodies were added 
directly to the co-culture. ICAM blocking antibody (Biolegend), CD18 blocking 
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antibody (Therno), SIRP1α blocking antibody (Biolegend), TNFα blocking 
antibody (Miltenyi) at a concentration of 10µg/ml. 
In some co-culture experiments neutrophils and MCs were separated by a 
transwell polycarbonate membrane (Corning Costar) with pores of 0,4 µm that 
allow the passage of soluble factors but not of cells. Neutrophils (0,6x 106) were 
cultured in the bottom chamber in a final volume of 600 µl while 0,2 x 106 MC 
were placed in the top chamber in a final volume of 100 µl. 
 
5.6. Flowcytometry 	  	  
Anti-CD11b (M1/70 clone), anti-Gr-1 (RB6-8C5 clone), anti-CD117 (c-kit, ACK2 
clone), anti-FcεRIα (MAR-1 clone), anti-CD40, anti -CD40L, anti-CD62L, anti-
CD19, anti-CD226, anti-CD5 were purchased from Biolegend. Anti-OX40, anti-
IL6 were purchased from e-Bioscience. Anti-TNFα, anti CD45, anti GITR, anti-
CD200R3 were purchased by Miltenyi. Anti-CD21, anti-CD23, anti-CD138 were 
purchased by BD Pharmigen. Anti-BAFF (Buffy 2 clone) was purchased by 
Abcam.  
Isotype control antibodies, Rat IgG2a, Rat IgG 2b, Rat IgG2bk purchased by 
Biolegend, Rat IgG2b, Rat IgG2a were purchased by e Bioscience. 
To assess cell-surface expression of different co-stimulatory molecules and/or 
activation markers, 3-4 x 105 cells were collected into polystyrene tubes 
(Sarstedt), washed with PBS and then incubated in the dark for 30 minutes at 
4°C with a fluorescent mAb. In case of multicolor staining, multiple fluorescent 
antibodies were added at the same time. After the incubation, the cells were 
washed with PBS, re-suspended in 0.3 ml of PBS and kept at 4°C until flow 
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cytometric analysis. 
Flow cytometry data were acquired on a FACSCalibur (BD Biosciences) and 
analyzed with FlowJo.  
 
5.7. Intracellular staining 	  	  
Neutrophils and MCs were co-cultured in RPMI 1640 supplemented with 10% 
FBS, 2 mM L-glutamine, 100U/ml penicillin, 100 µg/ml streptomycin. DNP 
(100ng/ml), LPS (10µg/ml), and brefeldin A (10 mg/ml; all from Sigma-Aldrich, 
St. Louis, MO) were added to the cells. After incubation for 3h or 12 hours cells 
were washed and incubated with FcR (50µl) blocking antibody, and Live/Dead 
(Invitrogen) for 15 minutes at 4°C. Washed cells were subsequently labeled 
with antibodies against surface molecules (FcεR, c-kit, GR1) at 4°C for 30 min 
and then labeled with the antibody of cytokines of interest (TNFα, IL6). 
The fixation and permeabilization of cells were performed using BD perm Wash, 
and BD Cytofix Cytoperm, according to the manufacturer’s instructions. To 
demonstrate the specificity of staining, isotype-matched control mAbs were also 
used. The stained cells were analyzed by flow cytometry. 
 
5.8. Degranulation assay: LAMP1 	  	  
IgE pre-sensitized BMMCs were challenged with DNP antigen (100ng/ml) in 
RPMI 10% FCS, 2 mM L-glutamine, 100U/ml penicillin and HEPES buffer. MCs, 
when indicated, were plated with equal number of neutrophils for 30 min 
concomitant to DNP challenge. After incubation samples were washed and 
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stained in the dark for 30 minutes at 4°C with the fluorescent marker LAMP1 
(Biolegend) 
 
5.9. Peritoneal cells 	  	  
 To obtain peritoneal cells, 5 to 10 ml of sterile PBS were injected into the 
peritoneal cavity of sacrificed mice using a sterile syringe with 23G needle. The 
abdomen was massaged and the cells and fluid were removed from the 
peritoneal cavity drawing with the syringe. The peritoneal cells were collected 
by centrifugation at 1800 rpm for 5 min and suspended to 1 x 106 to 2 x 106 
cells/ml in PBS. 
 
5.10. Blood cells 	  	  
 Blood cells were obtained by heart and tail. Heart: The animal was positioned 
on its back, the abdomen was opened and the heart visualized through the 
membranous part of the diaphragm. A 23G needle and a 1 ml syringe was used 
to obtain ~0,5 ml of blood which was immediately transferred to an eppendorf 
containing heparin. Part of blood was used for cell counting and flow cytomety 
after red blood cells lysis with a solution of ammonium chloride (1,5M NH4Cl; 
100mM NaHCO3; 10mM Na2EDTA; pH 7,4) 
The other part of blood was used for serum collection. 
Tail: The proximal part of the tail was incised and blood was collected in a tube 
containing sterile PBS. After red blood cells lysis cells were used in flow 
cytometry to monitoring neutrophils depletion.  
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5.11. Migration assay 	  	  
Chemotaxis was performed in a 96-transwell insert (Corning) with 5 µm pore-
size filters. 105 cells (in 75 µl) were plated in the upper layer of cell permeable 
membrane and solutions containing different stimuli were added in the lower 
compartment (for a total volume of 310 µl). After 4 hours, cells migrated in the 
lower chamber were counted and results expressed as fold induction compared 
to number of cells migrated in response of not-conditioned medium. 
 
5.12. ROS Production  	  	  
The amount of intracellular ROS was identified by flow cytometry using 2',7'-
dichlorofluorescein diacetate (DCFH-DA; Sigma-Aldrich). When applied on the 
cells, the non-ionic, non-polar, color- less DCFH-DA crosses cell membranes 
and is hydrolyzed enzymatically by intracellular esterases to non-fluorescent 
DCFH. In the presence of ROS, DCFH is oxidized to highly fluorescent 
dichlorofluorescein (DCF). Therefore, intra- cellular DCF fluorescence can be 
used as an index to quantify the overall ROS in cells. Neutrophils were stained 
in PBS with DCFH-DA for 10 minutes in dark at 37°C. After centrifugation the 
cells were incubated with MCs and different stimuli for 30 minutes in dark at 
37°C. To stop the reaction the cells were put in ice and were immediately 
analyzed by flow cytometry. 
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5.13. Detection of necrotic and apoptotic cells 	  	  
Necrotic and apoptotic cells were detected by labeling with annexin V and 
Propide Iodide using Annexin V-FITC Apoptosis detection Kit (eBioscience), as 
indicated. 2-4 x 105 cells were re-suspend in the provided Binding Buffer 1X and 
2,5 µL of Annexin V-FITC were added to 197,5 µL of cell suspension for 10 
minutes at room temperature. After a washing, cells were re-suspended in 200 
µL Binding Buffer with 5 µL of Propidium Iodide before performing FACS 
analysis. 
If required, cell surface staining was performed before Annexin staining. 
 
5.14. Cytokine and chemokine ELISA assays 	  	  
Supernatants from different experimental settings were collected at the indicate 
times for quantification of TNFα, TGFβ and IL-6 (e-Bioscience), BAFF (Boster 
Biological Technology, LTD), through ELISA test according to manufacturer’s 
protocol.  
 
5.15. T Independent Immunization 	  	  
On day 0, mice were injected intra-peritoneally with 25 µg of TNP(65)-AECM-
Ficoll  ( BIOSEARCH Technologies, Petaluma CA) in a total volume of 200µL of 
PBS. On day 8 after immunization, the blood was collect form each mouse and 
centrifuged at 1800 rmp for 15 minutes to separate serum. 
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5.16. IgM, IgG, IgA ELISA 	  	  
ELISA plate was prepared coating it overnight at 4°C with 5µg/ml TNP(30)-BSA 
(BIOSEARCH Technologies, Petaluma CA) in carbonate buffer (pH9). 
After snapping and washing the plate to remove the coating antigen the plate 
were incubated for 1-3 hours with PBS-BSA (0,5%) at 37°C. Each serum 
obtained from the immunization and from control mice was diluted in PBS-BSA 
(2µl of sera in 1ml of PBS). Several dilutions of sera were plate for 1 h at 37°C 
and then, after washing, HRP-conjugated anti mouse IgM, IgA or IgG3 
(Biolegend) diluted in PBS-BSA were added for 1h at 37°C. The plate was 
developed by adding 100 µL of room temperature TMB Sure Blue reagent per 
well and the reaction was stopped adding 100 µL of TMB Stop Solution. 
Absorbance was read at 450 nm. 
 
5.17. Neutrophils depletion 	  	  
C57BL/6 and KitW-sh/W-sh were injected intra-peritoneally (i.p) with 250 or 400 µg 
(for Whs mice) of anti Ly6G antibody (clone 1A8) or Isotype of control 
(clone2A3), purchased from BioXcell, the day before the immunization and 
every other days. Neutrophils depletion was monitored at different time point 
figure 5.17 controlling Ly6Ghigh/CD11b positive cells in mice tail blood. The 
depletion was carried on until the end of immunization. 
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Fig. 5.17 Neutrophil depletion in C57BL/6 and KitW-sh/W-sh mice after mAb anti-Ly6g administration. 
Representative example of FACS analysis to evaluate neutrophil depletion. T0 blood neutrophils in mice 
before depletion; T1 neutrophil presence in mice blood after the first i.p administration of mAb anti-Ly6g 
(clone 1A8); T4 neutrophil presence in mice blood two days after the second and before the thied 
administration of mAb anti-Ly6G; T8 neutrophil presence in mice blood the day of experiment. 
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5.18. Reconstitution of mast cell population in WSH mice  	  	  
5-6 weeks aged C56BL/6 mice were reconstituted by intra-peritoneal injection 
of 3x106 BMMC and used 5 weeks after reconstitution. 
 
5.19. Statistical analysis 	  	  
Results are expressed as the mean plus standard deviation (or standard error 
of the mean where specifically indicated). Data were analyzed using two-tailed 
Student t test. 
p < 0,05 was considered statistically significant. 
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